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ABSTRACT
Mechanoreceptor Activation in the Treatment of Drug-Use Disorders:
Mechanism and Outcome
Kyle Bills
Neuroscience Center, BYU
Doctor of Philosophy
The therapeutic benefits attributed to activation of peripheral mechanoreceptors are
poorly understood. There is growing evidence that mechanical stimulation modulates substrates
in the supraspinal central nervous system (CNS) that are outside the canonical somatosensory
circuits. This work demonstrates that activation of peripheral mechnoreceptors via mechanical
stimulation (MStim) is sufficient to increase dopamine release in the nucleus accumbens (NAc),
alter neuron firing rate in the ventral tegmental area (VTA) and increase membrane
translocation of delta opioid receptors (DORs) in the NAc. Further, we demonstrate that these
effects are dependent on DORs and acetylcholine receptors. Additionally, MStim can block
neuronal markers of chronic ethanol dependence including ethanol-induced changes to VTA
GABA neuron firing during withdrawal, and DA release profiles after reinstatement ethanol
during withdrawal. These are presented in tandem with evidence that MStim also ameliorates
behavioral indices of ethanol withdrawal. Finally, exercise, a modality that includes a
mechanosensory component, is shown to alter expression of kappa opioid receptors (KORs) in
the NAc. This change substantively depresses KORs influence over evoked DA release in direct
contraversion to the effects of chronic ethanol. These changes translate into reduced drinking
behavior.

Keywords: mechanoreceptors, dopamine, GABA, nucleus accumbens, ventral tegmental area,
delta-opioid receptors, kappa-opioid receptors, exercise, alcohol, cholinergic interneurons,
whole-body vibration
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CHAPTER 1: Introduction
Scope of the Problem
Alcohol addiction is a chronic relapsing disease that affects more Americans than all
forms of cancer combined (SAMHSA, 2016). It leads to destructive psychological, physical,
social, and economic consequences. It is estimated that over 28 million Americans are currently
in need of treatment for alcohol abuse, resulting in over $249 billion in direct costs (Sacks,
Gonzales, Bouchery, Tomedi, & Brewer, 2015). Making matters worse, only 13% of those
needing intervention actually receive it. Further, in spite of the wonderful advances in our
understanding of the neuropathophysiology of addiction, the success rate of treatment has not
substantively changed over the last hundred years, with around 50% of those treated relapsing
(Moos & Moos, 2006; SAMHSA, 2016; White, 2012) within a year. This represents
approximately 6% of those suffering from the disease receiving effective treatment. A report
ranking the different conditions relative to the “global burden of disease” found that alcohol
ranked 3rd out of the 25 major contributors (Lim et al., 2012). Developing new treatments looms
seismically as a determinant quest for addiction researchers until, at the least, outcomes are
markedly improved.
Mesolimbic Dopamine System and Dependence
The primary form of alcohol abused by humans is ethanol. It is clear that ethanol’s
rewarding and addictive properties are mediated, in large part, by dopamine (DA)
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neurotransmission in the
mesolimbic system.
Projections originate in
the ventral tegmental
area (VTA) of the
midbrain and travel to
the nucleus accumbens
(NAc) in the ventral

Figure 1.1: Simplified diagram of the mesolimbic circuitry.
DA - dopaminergic neuron; Ach, cholinergic interneuron;
GABA, GABAergic neuron.

striatum (Fig. 1.1).
Dopamine release in the NAc represents a scalar index of reward (Wise, 2008), with increased
levels associated with increased reward. Levels of DA increase with acute consumption of drugs
of abuse, providing a reinforcing stimulus for further use (Carboni, Imperato, Perezzani, & Di
Chiara, 1989; Yoshimoto, McBride, Lumeng, & Li, 1992). During the withdrawal state,
neuroplastic alterations occur in the mesolimbic DA circuit leading to hypofunction (Karkhanis,
Huggins, Rose, & Jones, 2016; Koeltzow & White, 2003; Maisonneuve, Ho, & Kreek, 1995;
Rose et al., 2016). This reduction in DA is theorized to be the primary driver of relapse as
blocking or ablating this pathway leads to dramatic decreases in drug self-administration (Lyness
& Smith, 1992). Although the prevailing dogma is that DA neurons projecting from the VTA to
the NAc mediate the rewarding and addictive properties of drugs of abuse (Wise, 2008), GABA
neurons in the VTA have garnered much interest of late for their role in modulating DA release
and as independent substrates mediating drug reward. Acute administration of cocaine, ethanol
and methamphetamine have been shown to cause inhibition of VTA GABA neurons (Gallegos,
Criado, Lee, Henriksen, & Steffensen, 1999; Ludlow et al., 2009; Steffensen et al., 2008;
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Steffensen et al., 2009; Stobbs et al., 2004), producing a net disinhibition of VTA DA neurons
(Bocklisch et al., 2013; Carboni et al., 1989; Yoshimoto et al., 1992). In contrast, in a state of
withdrawal, VTA GABA neurons undergo plasticity and become hyperactive (Bonci &
Williams, 1997; Gallegos et al., 1999; Hopf et al., 2007) leading to decreased mesolimbic DA
release in the NAc (Karkhanis et al., 2016; Koeltzow & White, 2003; Maisonneuve et al., 1995;
Rose et al., 2016). Understanding ethanol’s effects on the mesolimbic system is a singular
challenge. This difficulty stems, in part, from the fact that there is no known ethanol receptor,
rather a myriad of interactions between cell subtypes that change from acute to chronic exposure
and again in the withdrawal state.
Dopamine Receptors
Two distinct sub classifications of DA receptors are commonly described. These are the
D1 and D2 classes. Though the two families share a high degree of homology in their respective
transmembrane domains, pharmacologically, they are distinct. D1 family receptors, including
D1 and D5, are thought to be found on both pre- and postsynaptic membranes. In the ventral
striatum they can be found on GABA-ergic medium spiny neurons (Beaulieu & Gainetdinov,
2011). These receptors are coupled to Gαs G-proteins which ultimately increase the likelihood of
postsynaptic depolarization (Rankin & Sibley, 2010). The D2-like family of DA receptors
include D2, D3, and D4 receptor subtypes. The D2 subtype can be broken down further into two
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distinct isoforms, the long form (D2Lh)
and the short form (D2Sh). There is
currently much debate regarding their
relative locations and contributions. It
has been reported that the D2Sh subtype
are predominately presynaptic, though
this matter is not settled (Usiello et al.,
2000). D2 receptors, broadly, are
coupled to Gαi G-proteins. They cause a
Figure 1.2: Description of D2 receptors mechanism
of auto-inhibition of DA release. AC, adenylate
cyclase; PKA, Protein kinase A GIRK, G-proteingated inwardly rectifying K+ channel;

decrease in cAMP levels and subsequent
reduction in DA release (Fig. 1.2). D2
receptors produce an auto-inhibitory

feedback mechanism that is particularly important when studying ethanol, which acutely
increases DA levels and D2 receptor activity, and chronically, decreases DA levels and D2
activity. Dopamine 2 receptors are reportedly in flux as the mesolimbic system progresses from
acute ethanol exposure to a state of dependence. It is reported that ethanol preferring rats
demonstrate a reduction in D2 receptor density (McBride, Chernet, Dyr, Lumeng, & Li, 1993;
Stefanini et al., 1992; Strother, Lumeng, Li, & McBride, 2003). Further, ethanol preferring rats
show a reduction in D2 receptor efficacy (Hietala et al., 1994). These receptors are expressed on
cell bodies, dendrites and axons of cholinergic interneurons (CINs) in the NAc (Alcantara, Chen,
Herring, Mendenhall, & Berlanga, 2003). Accumbal CINs activate nicotinic acetylcholine (ACh)
receptors on DA terminals and increase DA neurotransmission (Yorgason, Zeppenfeld, &
Williams, 2017).
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Opioid Receptors
There are three well described classical opioid receptor (OR) types, kappa (KOR), mu
(MOR), and delta (DOR). Others types have been described and debated (ORL1, sigma, epsilon,
orphinan, etc…). We will focus on the three classical opioid receptors with implications to the
mesolimbic DA system. These receptors are coupled to Gi-proteins and produce inhibition
through several means, including inhibition of adenylate cyclase, reduction of calcium currents,
and activation of inwardly rectifying potassium channels (Attali, Saya, & Vogel, 1989; Henry,
Grandy, Lester, Davidson, & Chavkin, 1995; Konkoy & Childers, 1989; Prather et al., 1995;
Tallent, Dichter, Bell, & Reisine, 1994). They also activate a number of kinase cascades such as
the mitogen-activated protein kinase cascade (Fukuda, Kato, Morikawa, Shoda, & Mori, 1996).
Many ligands activate these receptors with most cross-activating between the three; though they
exhibit differing preferences. The main endogenous ligands involved in their activation are of
three classes, dynorphins, which are derived from the precursor protein pro-dynorphin and are
preferential for KORs (Aldrich & McLaughlin, 2009); enkephalins, which are derived from proopiomelanocortin and are preferential to MORs and DORs; and endorphins, which are also
derived from pro-opiomelanocortin and have a preference for MORs. These receptors are
similar in structure and have some overlap in ligand binding. Though activation of all receptor
types is associated with analgesia, MORs and DORs produce euphoria and increased risk for
dependence while KORs, conversely, when activated elicit dysphoria.
Kappa Opioid Receptors
KORs are expressed extensively in the NAc, both in the core and the shell (Mansour,
Burke, Pavlic, Akil, & Watson, 1996; Mansour, Khachaturian, Lewis, Akil, & Watson, 1987;
Spanagel, Herz, & Shippenberg, 1992), where their activation inhibits DA release (Spanagel et
al., 1992). Data suggests that they are synthesized in the cell bodies of DA neurons in the VTA
5

where they are expressed and also subsequently transported to terminals in the NAc where they
are integrated into the presynaptic membrane (Fig. 1.3) (Mansour, Fox, Akil, & Watson, 1995).
Activation of KORs is associated with dysphoria (Shippenberg, Zapata, & Chefer, 2007).
Evidence suggests that there is an upregulation of KORs in alcohol-dependent animals that may
play a role in the increased seeking behavior seen with dependence (Sirohi, Bakalkin, & Walker,
2012). This is demonstrated by a decrease in dependent-state seeking behavior when the KOR
antagonist nor-BNI is administered while having no effect on non-dependent animals (Walker &
Koob, 2008). Further chronic intermittent ethanol exposure has been shown to increase the
effect of KORs in the NAc. These data suggest a role for KORs in the synaptic adaptations that
accrue to alcohol dependence (Shippenberg et al., 2007).
Mu (MOR) and Delta (DOR) Opioid Receptors
In contrast to KORs, MORs and DORs are associated with euphoria, imparting to
agonists of these receptors a high potential for abuse (Devine & Wise, 1994). Activation
facilitates DA release in the NAc by two mechanisms. First, MORs and DORs act on local
GABA interneurons in
the NAc increasing DA
release, presumably,
through disinhibition of
DA terminals,
cholinergic
interneurons, and
glutamatergic
projections to the NAc

Fig 1.3: Location of mesolimbic opioid receptors
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(Fig. 1.3)(Hirose et al., 2005; Murakawa et al., 2004; Okutsu et al., 2006; Yoshida et al., 1999).
Second, MORs on GABA interneurons in the VTA disinhibit DA projections to the NAc (Bonci
& Williams, 1997; Johnson & North, 1992; Steffensen et al., 2006). Though some aspects of
MOR and DOR activity is similar, there are profound differences in their respective
contributions to ethanol dependence. Non-selective MOR and DOR antagonists have been
shown to decrease ethanol’s enhancement of DA release in the NAc in rats (Acquas, Meloni, &
Di Chiara, 1993; Benjamin, Grant, & Pohorecky, 1993; Lee et al., 2005). Interestingly, while
mice that lack MORs, or have them selectively blocked, appear immune to the reinforcing effects
of ethanol (Job et al., 2007; Roberts et al., 2000), those that lack DORs demonstrate an increase
in ethanol seeking behavior (Roberts et al., 2001).
Recently, evidence has emerged implicating DORs in the mesolimbic effects of a targeted
mechano-acupuncture treatment when given at the HT7 acupoint, located medial to the flexor
carpi ulnaris tendon at the wrist. This mechanically-based treatment activates peripheral
mechanoreceptors and excites the traditional somatosensory pathway from spine to nucleus
cuneatus to thalamus (Chang et al., 2017). Interestingly, it has been shown to influence VTA
GABA neurons, producing a transient inhibition in their firing and reducing ethanol-seeking
behavior in rodents (Chang et al., 2017; Yang et al., 2010).
Mechanoreceptors as possible therapeutic targets for drug-use disorders
Previously, low and medium (2-100 hz) frequency electroacupuncture, which activates
peripheral mechanoreceptors, has been shown to activate enkephalinergic and betaendorphinergic neurons in the arcuate nucleus (Wang, Mao, & Han, 1990a, 1990b), which in
turn inhibit GABA neurons, likely, via activation of mu- and delta-opioid receptors (MORs and
DORs) (Mansour, Khachaturian, Lewis, Akil, & Watson, 1988; Yang et al., 2010). Further
7

acupuncture modulates VTA GABA neurons via somatosensory pathways and reduces ethanol
and cocaine psychomotor effects and drug-seeking behavior (Chang et al., 2017; Jin et al., 2017;
Kim et al., 2013; Yang et al., 2010; Yoon et al., 2012). Stimulation at HT7 (Shenmen acupoint)
activates the dorsal column medial lemniscal (DCML) pathway, synapses in the nucleus
cuneatus (CN) and subsequently relays through the thalamus and lateral habenula before finally
modulating the excitability of VTA GABA neurons (Chang et al., 2017), presumably through
DORs that are expressed on GABA neurons in the NAc core greater than the shell (Hipolito,
Sanchez-Catalan, Zanolini, Polache, & Granero, 2008). We hypothesize that activation begins
with peripheral mehcanoreceptors, such as Meissner’s, Pacinian corpuscles, and Merkel cells and
ends wth DORs in the NAc. It is generally accepted that these receptors possess “optimal”
frequency ranges in which they are most active. Merkel cells become more responsive with
increased frequency and amplitude of stimulation in a near linear relationship from
approximately 1-100 Hz and 1-1500 µm respectively (Rowe, Tracey, Mahns, Sahai, & Ivanusic,
2005). Meissner’s corpuscles are considered to become optimally activated at frequencies
around 50 Hz (Macefield, 2005), while Pacinian corpuscles optimally respond to higher
frequencies beginning as low as 100 Hz, but optimally in the range of 200-400 Hz (Biswas,
Manivannan, & Srinivasan, 2015). The clarification of the neurological pathway underlying
HT7’s mesolimbic effects suggests that activation of the pathway generally will be sufficient to
produce the same effect.
Scope of the Work Performed in This Dissertation
To this point, several important factors underlying the use of mechanoreceptor
stimulation in the treatment of drug abuse remain to be elucidated, including, determining
whether mechanoreceptor activation alone is sufficient to alter mesolimbic function, critical
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neuronal substrates activated, regional specificity of receptor activation, optimal vibrational
frequency of mechanical stimulus, optimal duration of treatment and behavioral efficacy of the
treatments in question. To this end, we originally proposed 2 specific aims to address these
questions.
Aim 1: To define the mechanism underlying the effects upon VTA GABA, DA neurons and NAc
DA release elicited by subcutaneous vibration at the C7-T1 laminae and HT7. The previously
published literature combined with our preliminary data suggest that stimulation of the DCML
neurological pathway will be sufficient to produce changes in the mesolimbic system. This aim
sets out to show these effects, define the DCML and opioid receptors as mechanistically
involved and describe the optimal vibrational frequency and duration for maximal effect. The
hypothesis is that subcutaneous vibration will: 1) Produce a transient increase followed by a
longer decrease in VTA GABA neuron firing rate and that vibration at HT7 and the C7-T1
laminae will produce the same changes; 2) Cause an increase in VTA DA neuron firing rate; 3)
Increase evoked DA release in the NAc; 5) Exhibit a dose dependent response; and 6) Be
reversed by ablation of the DCML or administration of naltrindole. These hypotheses will be
tested with in vivo electrophysiology, and in situ NAc fast-scan cyclic voltammetry to evaluate
phasic and spontaneous DA release, respectively.
Aim 2: Evaluate the effects of subcutaneous vibration as an attenuator of cocaine psychomotoractivating effects, self-administration and ultrasonic vocalizations.
Acute cocaine exposure has been shown to increase 50 KHz ultrasonic vocalizations and
locomotor activity in rats. HT7 acupuncture has been shown to effectively decrease these
psychomotor activities as well as self-administration. The hypothesis is that subcutaneous
vibration or optogenetic stimulation will: 1) Decrease 50 KHz ultrasonic vocalizations and
9

locomotor activity in rats after acute cocaine exposure; 2) Decrease cocaine self-administration;
and 3) Reduce the effects of acute cocaine exposure on VTA GABA and DA neurons and DA
release in the NAc via their activation of DCML neurological pathway. These hypotheses will be
tested with behavioral assays, in vivo electrophysiology, and voltammetry.
Originally, the aims were narrowly focused on acupuncture as a modality. As our understanding
increased, so did our scope, with expansion to mechanical stimulation of the cervical vertebrae at
the C7-T1 level (MStim). After completing the studies outlined in Aim 1, it became clear that
the effects elicited by MStim were robust and carried translational potential as a treatment for
drug-use disorders. Our aims changed to accommodate a more complete understanding of the
mechanistic nature of MStim-induced effects on the mesolimbic circuitry. In addition to the
studies proposed we evaluated DA release in the NAc via microdialysis and pharmacologically
studied the importance of DORs both systemically and locally in the VTA and NAc. Further, we
looked at the importance of acetylcholine release in the NAc as a mediator of terminal DA
release and the preeminence of the NAc as the mesolimbic entry point of MStim and the driver
of VTA changes. Through immunohistological (IHC) methods, we examined the expression
patterns of DORs in the VTA and NAc in response to MStim. These findings are described in
Chapter 3. Aim 2 was changed substantively as well. Again, because of the translational
potential of this treatment, we felt it more relevant to examine its effects on the withdrawal state
rather than the acutely intoxicated state. Therefore, we studied MStim effects on chronic ethanol
withdrawal. We examined VTA GABA neurons and DA release patterns in the NAc. We also
measured behavioral metrics of withdrwawal (Chapter 4). Finally, because of the broadened
impact of MStim as opposed to acupuncture alone. We performed a study to investigate exercise
induced alterations to chronic ethanol exposure. We examined these effects in the context of
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KORs using fast-scan cyclic voltammetry and IHC staining. We also measured ethanol drinking
behavior via a drink-in-the-dark paradigm (Chapter 5).
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CHAPTER 2: Targeted Subcutaneous Vibration with Single-Neuron Electrophysiology as a
Novel Method for Understanding the Central Effects of Peripheral Vibrational Therapy in a
Rodent Model
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Abstract
Very little is known about the effects of whole body vibration on the supraspinal central nervous
system. Though much clinical outcome data and mechanistic data about peripheral neural and
musculoskeletal mechanisms have been explored, the lack of central understanding is a barrier to
evidence-based, best practice guidelines in the use of vibrational therapy. Disparate methods of
administration render study to study comparisons difficult. To address this lack of uniformity, we
present the use of targeted subcutaneous vibration combined with simultaneous in vivo
electrophysiological recordings as a method of exploring the central effects of peripheral vibration
therapy. We used implanted motors driven by both Grass stimulators and programmed micro
controllers to vary frequency and location of stimulation in an anesthetized in vivo rat model while
simultaneously recording firing rate from GABA neurons in the ventral tegmental area. We show
peripheral vibration can alter GABA neuron firing rate in a location and frequency dependent
manner. We include detailed schematics and code to aid others in the replication of this technique.
This method allows for control of previous weaknesses in the literature including variability in
body position, vibrational intensity, node and anti-node interactions with areas of differing
mechanoreceptor densities, and prefrontal cortex influence.

22

Introduction
Vibrational therapy, through the use of whole body vibration (WBV) platforms or localized
peripheral vibration (LPV), is increasing in popularity. Early investigations looked at vibrationinduced enhancement of physical performance such as power and strength1, and this body of
literature is now extensive. Over the last 15 years, the vibration literature has rapidly expanded to
include studies on a variety of responses ranging from flexibility2,3 and balance4, to bone
metabolism5, hormone release6, and aging and loss of balance7. The application of vibration
stimulates mechanoreceptors in the skin, muscle, and joint which influence monosynaptic and
polysynaptic pathways in the peripheral and central nervous systems (PNS and CNS). Much of
the initial explanation regarding the functional efficacy of WBV or LPV has focused on peripheral
neuromechanical alterations.

Early work utilizing LPV directly to a tendon or muscle helped establish peripheral
neuromechanical responses to vibration. Vibration can invoke the stretch reflex by exciting group
Ia afferents8, while secondary afferents and Golgi tendon organs (GTO) show a decreased
response to vibration input9. However, the firing rate of both afferents and the GTO response
increase with muscle contraction9,10. Other studies suggest that both the H-reflex and stretch reflex
are suppressed during vibration due to pre-synaptic inhibition11, and that this suppression is
sustained following application of WBV12,13. Weight bearing activities and exercise application
of WBV on reflex responses appears more controversial with load-bearing movement and
complexity of tasks possibly interfering with assumed neuromechanisms12. More recently,
however, the variability in results of similar studies and the broadening of vibration application
for study has suggested a more important role of central or supraspinal influence. Reflex
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contraction appears dependent on efferent fusimotor input, which suggests supraspinal control is
involved14. Current research observing the effects of vibration on symptoms of various medical
conditions including stroke15 and Parkinson’s disease16, amongst others17, suggests that WBV is a
safe and beneficial method for improving these symptoms, as well as general movement patterns,
gait, and balance. Evaluation of such conditions offers further evidence that supraspinal and
central mechanisms are involved in the body’s responses to vibration input. Reports of enhanced
corticospinal excitability concomitant with spinal inhibition18 and facilitated motor evoked
potentials19 further highlight the enhanced role of the central nervous system in modulating
responses to vibration. The concomitant increased cortical excitability seems to compensate for
lower excitability at the spinal level20.

Touch (both fine and crude) pathways such as the dorsal column/medial lemniscal pathways
(DCML) and pain/temperature pathways (anterolateral columns) are well defined in both texts and
research literature regarding their structures and regions crossed as information is relayed from a
peripheral receptor to the somatosensory cortex. However, activation of specific mechanoreceptor
responses within a defined area and their effects on central neuron activity remains largely
unknown. Mechanical stimulation of the DCML pathway via mechanoacupuncture at the wrist
has been shown to produce modulatory effects in -aminobutyric acid (GABA)-containing
neurons in the midbrain ventral tegmental area (VTA)21. Further these effects have been traced
through synapses in the nucleus cuneatus (CN) and subsequent relays through the thalamus and
lateral habenula before finally producing inhibition of VTA GABA neurons21. Thus, groundwork
has been laid demonstrating, indirectly, that peripheral mechanoreceptor activation affects higher
order functions of the CNS (e.g., limbic), beyond simple somatosensory processing. There is also
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compelling evidence demonstrating central changes in response to mechanical vibration as
measured with fMRI, EEG, heart rate variability and evoked potentials18,22-24. Unfortunately, the
lack of better detail to supraspinal responses is still an impediment to the development of evidencebased therapeutic guidelines and consensus on vibration’s therapeutic value and mechanism of
action. The use of fMRI lacks temporal and spatial resolution and primarily gives regional
specificity and indirect information about neuron activity. Conversely, the use of EEG offers
improved temporal resolution but lacks regional specificity. Evoked potentials give information
about a change in the facilitation/inhibition of the entire pathway with limitations similar to EEG.
Heart rate variability also lacks spatiotemporal resolution and is, at best, a generalized indirect
measure of autonomic nervous activity. These deficiencies underpin the need for novel methods
of investigation to determine how peripheral mechanical vibration affects central activity. These
previous methods leave a gap in the ability to understand how individual neurons within a targeted
area respond to LPV.

In this paper, we lay out the application of localized subcutaneous vibration with simultaneous invivo single neuron electrophysiology. This technology has been a long-standing and commonly
used technique to measure changes in neuron firing rate in response to various experimental
conditions. However, to date, it has not been applied to the field of clinically applied vibration.
Use of this technique can further our understanding of the non-canonical effects of LPV. Not only
does this method give us the ability to understand the individual neuron response to LPV, but it
also allows us to control the application of the peripheral vibration (region, frequency, and
amplitude). To demonstrate the utility of this technique, we aimed to test regional and frequencybased differences in LPV on GABA neuron firing rate in the VTA. To test this, we implanted
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subcutaneous vibrating motors in two different regions (posterior neck C7-T1 and the biceps
femoris of the posterior hindlimb) of wistar rats. Further, we tested the difference between 50 Hz
and 115 Hz at the C7-T1 level of the spinal column. We hypothesized that regional and frequencybased differences would produce disparate changes in GABA neuron firing rate due to differences
in both mechanoreceptor density and specificity.

Materials and Methods
Vibrational Motors
The vibration excitation source used in this research was a
3 volt, DC coin vibration motor (10 mm x 2.7 mm, DC
3V/0.1A, Uxcell, Hong Kong, CN). This motor induces
vibration due to a rotating unbalance. The motor is encased
in a small circular disc with a 10 mm diameter and 2.7 mm
length. The weight of the motor was 6 g. A photograph of
Figure 2.1: Vibrational Motor.

the motor is shown in Figure 2.1.
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To ensure proper excitation to the system through predictable output, the vibration output of the
motor was evaluated. The procedure consisted of
configuring the motor input voltage and then randomly
selecting one of the predetermined frequencies. The
motor output velocity was measured 10 times at each
frequency and voltage setting using a laser Doppler
vibrometer (LDV). The LDV provided a non-intrusive
measurement without adding any mass to the motor.
The displacement and acceleration were computed from
the velocity measurements. Two input voltage settings
of 1 volt and 2 volts were used. The frequencies tested
were at every 10 Hz ranging from 40 Hz to 160 Hz.

The motor characterization results are shown in Figure

Figure 2.2: Motor displacement and
acceleration by frequency. (A)
Displacement. (B) Acceleration.
The dots on the graphs represent an
average of 10, test samples and the
vertical lines at each data point
represent one standard deviation

2.2. Figure 2.2A shows the amplitude of the motor output displacement as a function of frequency.
The displacement data show a relatively flat frequency response from 80 Hz to 150 Hz. Figure
2.2B shows the acceleration versus frequency data for the motor. As expected, the acceleration
output increases quadratically with frequency. From these data, it was determined that this motor
had a fairly flat frequency response across the frequencies of interest and was sufficiently
characterized to produce sufficiently repeatable results for the experiments described below.

Surgical Procedure and In Vivo Single Cell Electrophysiology
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Wistar rats, weighing 250-320 g, from our breeding colony at Brigham Young University were
used. Rats were housed in groups of 2-3 at a fixed temperature (21-23°C) and humidity (55-65%)
on a reverse light/dark cycle with ad libitum food and water. Rats were anesthetized using
isoflurane and placed in a stereotaxic apparatus. Anesthesia was then maintained at 1%. Body
temperature was maintained at 37.4° ± 0.4°C by a feedback regulated heating pad. A 10 mm
incision was made either at the C7-T1 levels posteriorly at midline or at the ipsilateral biceps
femoris muscle. The Fascia was dissected and muscle tissue was left intact. A 10 mm x 2.7 mm,
DC 3V/.1A micro coin vibration motor (Uxcell, Hong Kong, CN), was then implanted
subcutaneously (to the right of midline for cervical implant) and the incision was closed
adhesively. Extracellular potentials were recorded by a single 3.0 M KCl-filled micropipette (2 to
4 Mohms; 1-2 μm inside diameter). With the skull exposed, a hole was drilled for placement of
the pipette which was driven into the VTA with a piezoelectric microdrive (EXFO Burleigh 8200
controller and Inchworm, Victor, NY) via stereotaxic coordinates [from bregma: 5.6 to 6.5
posterior (P), 0.5 to 1.0 lateral (L), 6.5 to 7.8 ventral (V)]. Potentials were displayed on a digital
oscilloscope and amplified with an Axon Instruments Multiclamp 700A amplifier (Union City,
CA). Single-cell activity was filtered at 0.3 to 10 kHz (3 dB) with Multiclamp 700A and sampled
at 20 kHz (12 bit resolution) with National Instruments acquisition boards. Extracellularly
recorded action potentials were discriminated with a WPI, WP-121 Spike Discriminator (Sarasota,
FL). Single-unit potentials, discriminated spikes, and stimulation events were captured by National
Instruments NB-MIO-16 digital I ⁄O and counter⁄timer acquisition boards (Austin, TX) in Mac
computers.

Characterization of VTA GABA Neurons in vivo and Recordings
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VTA GABA neurons were identified by previously-established stereotaxic coordinates and by
spontaneous and stimulus-evoked electrophysiological criteria. They included: relatively fast
firing rate (>10Hz), ON-OFF phasic non-bursting activity, and spike duration less than 200 µsec.
We evaluated only those spikes that had greater than 5:1 signal-to-noise ratio. After positive
GABA neuron identification, baseline firing rate was measured for 5-minutes to ensure stability
prior to vibratory stimulus.

Grass Stimulator and Vibration Stimulation
Following measurement of the GABA neuron baseline firing rate, a 60-second vibration stimulus
was introduced. The vibrating motor was connected to the S44 Grass Stimulator (Grass Medical
Instruments, West Warwick, RI). For electrophysiological recordings, the stimulator was set at 2
volts for 0.1 msec duration and 0 msec delay. Pulses per second were varied to produce variations
in vibrational frequency. All vibratory stimuli were 60 sec in duration and followed by 15-min of
recording the GABA neuron firing rate. Experimental groups included 50 Hz (n=4) and 115 Hz
(n=4) given subcutaneously at the C7/T1 level and 50 Hz (n=4) given subcutaneously at the right
biceps femoris muscle.

Micro Controller Driver
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In order to facilitate the replication of this
technique we include an alternative method
for generating the vibratory stimulus using a
PIC24F16KA301

micro

controller

to

generate a pulse width modulation (PWM)
signal.
emulate

This PWM can be modified to
multiple

signals

of

varying

Figure 2.3 – Circuit for micro controller

frequency and amplitude. The PWM is then passed through a transistor that provides the needed
current to the motor. The full circuit is pictured in Figure 2.3 and the schematic and code to drive
the micro controller can be found at http://github.com/steffensenlab.

Statistical Analysis
Single‐unit, discriminated spikes were processed with IGOR Pro software (Wavemetrics, Lake
Oswego, OR). Extracellularly recorded single‐unit action potentials were discriminated by a peak
detector digital processing LabVIEW algorithm. After 5-min of recording, the final 60 sec of firing
rate data before vibrational stimulus were averaged to establish a baseline for comparison. The
results for control, 50 Hz and 115 Hz vibrational groups were derived from calculations performed
on ratemeter records and expressed as means ± SEM. All statistical tests were performed in
JMP13. Data from each recording were normalized and combined and binned in 100 sec intervals
for comparison across time. All comparisons were initially made using a one-way ANOVA.
Following the ANOVA, all groups and bins were compared to corresponding controls using a
Dunnett’s analysis. The control group was established by taking firing rate data from GABA
neurons in rats that received no vibratory stimulation but did receive subcutaneous implants of
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vibrating motors which were placed near the cervical spine as described previously. Baseline
recordings (n=4) were normalized and combined prior to
comparison with experimental groups. Figures were
compiled using IGOR Pro Software.

Results
Figure 2.4 demonstrates the three LPV
experimental conditions that were tested and compared
to unstimulated baseline. Figure 2.4A shows stimulation
at the right hind leg. A vibrational stimulus at this
location of 50 Hz for 60 sec showed no significant change
in GABA firing rate over any time frame. Figure 2.4B
demonstrates the effects of a 115 Hz stimulation at C7-T1
for 60 sec. As with stimulation to the hind leg, 115 Hz
did not show a change in GABA firing rate across any
time. In contrast, Figure 2.4C reveals a depression in
GABA neuron firing rate resultant from a 50 Hz vibration
at C7-T1 for 60 sec. Initial ANOVA revealed differences
between bins at 101-200 [F(3,11) = 16.7675, p=0.0002]
and 201-300 sec [F(3,11) = 19.51, p = 0.0001]. After 50
Hz stimulus was given at 100 sec, from time 100 to 200
sec, GABA neuron firing rate depressed to 48.3% (± 3.2%,
n=4, p<.0001) of baseline and to 45.9% (± 7.3%,
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Figure 2.4: Effects of variable
frequency and local
subcutaneous vibrational
stimulus on GABA neuron
firing rate in the VTA. (A, B)
50Hz stim given at right hindleg
(A) and 115 Hz stim given at
cervical spine (B) show no
effect on VTA GABA neuron
firing rate. C- 50 Hz stim at
cervical spine causes a 52.9%
reduction in GABA firing rate
from 100 to 300 sec.

n=4, p<.0001) of baseline from 200 to 300 sec. No other time frame or experimental condition
produced a significant change in firing rate.
Figure 2.5A shows group data comparing firing rate
averages of all locations and frequencies from time of
vibrational stimulus to 400 sec post-stimulation.
Analysis revealed significant differences between
average vibration-induced firing rate depression
between groups [F(3,11) = 7.14 , p = 0.006]. 50 Hz
stimulation at the right C1-T1 laminae produced an
average depression to 69.2% (±3.0%, n=4, p =
0.0002) of baseline and was the only stimulus to
produce a significant reduction in firing rate over
time. Panel B compares the greatest firing rate
depression produced in each experimental group.
Because VTA GABA neurons exhibit a natural
cyclical ebb and flow some variation is expected even
within the unstimulated group. There was a

Figure 2.5: Group data showing
average and maximal GABA
neuron firing rate depression from
baseline. (A) 50 Hz stim to the
cervical spine produces an average
depression to 69.2% of baseline.
(B) 50 Hz stim to the cervical
spine produces an average
maximal depression to 24.8% of
baseline.

significant difference between the minimum firing
rates of the four experimental groups [F(3,11) = 7.8545, p = 0.0044]. Unstimulated baseline
recordings produce a maximal drop to 78.1% (± 0.4%, n=4) of averaged baseline. All other
maximal depressions were compared to the variation in the baseline group. 50 Hz vibration to the
cervical spine produced an average maximal drop in firing rate to 24.8% (±1.4%, n=4, p = 0.003)
of baseline. No other group produced a significant inhibition to firing rate.
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Discussion
These findings are suggestive that LPV produces transient changes to cellular excitability in the
VTA. Further, that vibrational frequency and location of stimulus are important factors in
peripheral vibration-induced changes. The sites of stimulation were chosen due to their disparate
relative levels of mechanoreceptor expression in the subcutaneous tissue and adjacent joint
capsules. In humans, high levels of cutaneous and joint mechanoreceptors have been identified in
the intervertebral disc and facet joints of the spine, with greater relative levels in the cervical spine
than thoracic or lumbar25,26. The control stimulation was chosen due to its distance from joint
mechanoreceptors. The motor implant site provided at least 20 mm of distance between the motor
and the nearest joint. Further, there is a lack of cutaneous Pacinian corpuscle expression in rodents
enhancing the effect of increased distance from joint
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. The two frequencies of vibration were

chosen to more selectively activate either Meissner’s corpuscles or Pacinian corpuscles; the former
having a lower intensity dynamic range of around 5-100 Hz and the latter a higher range of around
100-300 Hz 28-31. However, it is noted that these ranges are commonly thought to be approximate
and some overlap certainly exists. A small population of lanceolate endings exist that have been
shown to respond to vibration in a range around 5-200 Hz, though this population of endings has
only been demonstrated in recordings of cat whisker hair 32. Other common cutaneous and joint
mechanoreceptors are thought to be more specific to light touch (Merkel Cells) and stretch (Ruffini
corpuscles) and thus are less likely to be significant in the presence of prolonged vibrational input
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. 50 and 115 Hz vibrational frequencies were chosen to more selectively target Meissner’s and

Pacinian Corpuscles respectively.
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VTA GABA neuron activity transiently and significantly decreased after targeted subcutaneous
vibration at the C7-T1 level when stimulation occurred at 50 Hz. These changes were not present
when stimulation was given at 115 Hz or when stimulation was given at the muscle belly of the
biceps femoris muscle of the upper hind leg. Additionally, they suggest that targeted,
anatomically-specific and frequency-variable vibration, coupled with single-unit extracellular
electrophysiology is an effective method for measuring direct alterations in neuronal firing rate
resultant from peripheral vibration. A previous study recording GABA neuron firing rate changes
in the VTA due to acupuncture treatment suggested that receptor sensitivities might be responsible
for the reported frequency dependent effects on these neurons 34. GABA neurons in the VTA were
chosen due to internal preliminary data indicating their responsiveness to peripheral vibration and
because of their relevance in addiction research34-36. This method can be employed to further
clarify regional and frequency based sensitivities, mechanoreceptors subtypes, and tractology
involved in alterations of central neuronal function. To our knowledge this method has not been
applied to the field of therapeutic vibration. It can provide a framework for ongoing description
of the central pathways involved in this emerging field of physical medicine.

Future Direction
It is unknown the extent to which higher order neuronal processing affects the currently observed
effects of WBV such as improvement in gait, movement patterns and balance. By extension, even
less is understood about the changes that occur primarily in these higher circuits. This lack of
understanding is a major impediment to our ability to develop optimized, evidence-based care
protocols and could contribute to the mixed outcome data surrounding both WBV and LPV, and
their therapeutic applications. The diversity of vibrational testing protocols divergent in
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frequency, duration, type, amplitude, resonant location and subject positioning render inference
about precise neural mechanisms difficult. The lack of homogenous testing protocols could
contribute to the mixed reports of the efficacy of WBV in the treatment of various conditions 37,38.
Indeed, it has been shown that slight variations in a subject’s posture or weight distribution can
greatly affect the transmission of vibratory stimuli through the body 39. Future studies should focus
on addressing these issues, specifically tracking the cellular and circuitry changes that contribute
to current therapeutic applications and outcomes from WBV. Frequency and regional specificity
along with duration or treatment must be addressed in order to maximize patient outcomes. These
answers will be difficult to ascertain without directly measuring circuitry of interest in animal
models and human subjects for each condition for which WBV is a potential therapy. An
understanding of cellular and circuitry changes could provide insight into applications not
currently being considered, including methods such as deep brain stimulation or genetic therapies.
Localized subcutaneous vibration with simultaneous in vivo single-unit electrophysiology can
provide heretofore lacking information about individual neuronal changes in the central nervous
system. Filling this gap may help provide a more complete picture of the central effects of
vibratory therapeutics and lead to improved continuity of application and outcome in the future.
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Figure Legends
Figure 2.1: Vibrational motor
Figure 2.2: Motor displacement and acceleration by frequency
(A) Displacement. (B) Acceleration. The dots on the graphs represent an average of 10, test
samples and the vertical lines at each data point represent one standard deviation above and
below the indicated value
Figure 2.3: Circuit for micro controller driving motor
Figure 2.4: Effects of variable frequency and locale subcutaneous vibrational stimulus on GABA
neuron firing rate in the VTA
(A, B) 50Hz stim given at right hindleg (A) and 115 Hz stim given at cervical spine (B) show no
effect on VTA GABA neuron firing rate. C- 50 Hz stim at cervical spine causes a 52.9%
reduction in GABA firing rate from 100 to 300 sec.
Figure 2.5 Group data showing average and maximal GABA neuron firing rate depression from
baseline
(A) 50 Hz stim to the cervical spine produces an average depression to 69.2% of baseline. (B) 50
Hz stim to the cervical spine produces an average maximal depression to 24.8% of baseline.
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CHAPTER 3: Mechanical stimulation of cervical vertebrae modulates the discharge activity of
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Abstract
The therapeutic benefits attributed to activation of peripheral mechanoreceptors are poorly
understood. There is growing evidence that mechanical stimulation modulates substrates in the
supraspinal central nervous system (CNS) that are outside the canonical somatosensory circuits.
The aim of this study was to evaluate the effects of mechanical stimulation applied to the cervical
spine at the C7-T1 level (termed “MStim”) on neurons and neurotransmitter release in the
mesolimbic dopamine (DA) system, an area implicated in reward and motivation. Utilizing
electrophysiological, pharmacological, neurochemical and immunohistochemical techniques in
male Wistar rats we demonstrate that low frequency (45-80 Hz), but not higher frequency (115
Hz), MStim inhibited the firing rate of ventral tegmental area (VTA) GABA neurons (52.8%
baseline; 450 sec) and concomitantly increased the firing rate of VTA DA neurons (248% baseline;
500 sec). Inactivation of the nucleus accumbens (NAc), or systemic or in situ antagonism of delta
opioid receptors (DORs), blocked MStim inhibition of VTA GABA neuron firing rate. MStim
enhanced both basal (178.4 % peak increase at 60 min) and evoked DA release in NAc (135.0 %
peak increase at 40 min), which was blocked by in situ antagonism of DORs or acetylcholine
release in the NAc. MStim enhanced the number of cells expressing c-FOS in the NAc, but
inhibited total expression in the VTA, and induced translocation of DORs to neuronal membranes
in the NAc. These findings suggest that MStim acts through endogenous opioids in the NAc to
modulate DA release in the mesolimbic DA system. These findings demonstrate the need to
explore more broadly the extra-somatosensory effects of peripheral mechanoreceptor activation
and the specific role for mechanoreceptor-based therapies in the treatment of substance abuse.
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Significance Statement
This research is the first to mechanistically describe a rationale for further exploration of physical
medicine in the treatment of substance abuse. It is also the first to describe, mechanistically, robust
and specific modulation of supraspinal brain circuits in response to targeted peripheral mechanical
stimulation. It lays the groundwork for future studies to explore the effects of mechanical
stimulation on other brain regions.
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Introduction
The use of mechanoreceptor-based therapies in the treatment of drug-abuse disorders is a largely
unexplored field. Indeed, the role of mechanoreceptors other than as canonical mediators of
somato-sensation has only become relevant in recent years. Whole body vibration (WBV) has
been shown to positively impact power and strength [1], flexibility [2, 3], balance [4], bone
metabolism [5], hormone release [6], and falls in the elderly [7]. Notably, several complementary
health care approaches are thought to have effects mediated in part by activation of
mechanoreceptors, including chiropractic medicine, acupuncture, and physical therapy. Early
understanding of the mechanisms underlying mechanoreceptor-based therapies such as WBV
centered on peripheral neuromechanical alterations. Recent reports have included evidence of
increased cortical excitability [8], increased motor evoked potentials [9], and compelling evidence
demonstrating CNS changes in response to peripheral mechanical stimulation as measured with
fMRI, EEG, heart rate variability, and evoked potentials [8, 10-12]. Notwithstanding these gains,
our understanding of the CNS changes induced by peripheral mechanical stimulation remains
understudied, and perhaps undervalued.
Midbrain dopamine (DA) neuron activity is involved in many aspects of reward seeking [13-15].
Although the prevailing dogma is that DA neurons mediate the rewarding and addictive properties
of drugs of abuse [16], VTA GABA neurons have garnered much interest for their role in
modulating DA neuronal activity and DA release and perhaps as independent substrates mediating
reward or aversion [17-23]. We have shown previously that acute administration of ethanol,
opioids, or cocaine inhibits VTA GABA neurons [17-21, 24], leading to a net disinhibition of VTA
DA neurons [25-27]. In contrast, during ethanol or opioid withdrawal, VTA GABA neurons
become hyperactive [17, 28] leading to decreased mesolimbic DA activity and release in the NAc
[29-33]. This reduction in mesolimbic DA transmission is theorized to be the primary driver of
relapse [34].
There is compelling evidence suggesting that some of the benefits ascribed to acupuncture are
mediated through somatosensory neuronal pathways. We have shown in multiple reports that
stimulation of the HT7 acupoint modifies drug-seeking behaviors and relapse to cocaine [35, 36],
methamphetamine [37], and ethanol [38]. These effects can be attenuated with ablation of the
dorsal column/medial lemniscal pathway and appear to act through endogenous opioids [39-41].
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Though these studies demonstrate anatomically site-specific effects, they are suggestive that
activation of primary somatosensory fibers generally may attenuate the reinforcing effects of drugs
of abuse.
In this study, we hypothesized that mechanical stimulation of the cervical spine at C7-T1 (termed
“MStim”) is sufficient to modulate neuronal activity in the VTA and neurotransmitter release in
the NAc and that this effect is driven by activation of endogenous opioids. We have recently
reported that MStim of the cervical spine modifies the activity of VTA GABA neurons [42]. Here
we extend these studies to include the recording of VTA GABA and DA neurons, DA release, and
mechanistic studies demonstrating the role of endogenous opioid release in mediating
mechanoreceptor activation of the mesolimbic DA system.
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Materials and Methods
Vibrational Motors
A 3 volt, DC coin vibration motor (10 mm x 2.7 mm, DC 3V/0.1A, Uxcell, Hong Kong, CN) was
used as the source of vibrational stimulation. The motor, which was encased in a small circular
disc with a 10 mm diameter and 2.7 mm width, created vibration due to off-centered weight
attached to the motor’s rotational shaft. The weight of the motor was 1.5 g and its specifications
and performance were as previously reported [42].
Animals and MStim Motor Implantation
Male wistar rats, weighing 250-320 g, from our breeding colony at Brigham Young University
were used. Rats were housed in groups of 2-3 at 21-23°C and humidity (55-65%) on a reverse
light/dark cycle with ad libitum food and water. A 10 mm incision was made either at the C7-T1
levels posteriorly at midline or at the ipsilateral biceps femoris muscle. The fascia was dissected
and muscle tissue was left intact. A DC micro coin vibration motor was implanted subcutaneously
(to the right of mid-line for cervical implant) and the incision was closed with surgical adhesive
tape to maintain consistent motor placement.
Single Cell Electrophysiology
For recordings of VTA GABA neurons, rats were anesthetized using isoflurane and placed in a
stereotaxic apparatus. Anesthesia was maintained at 1.5% with 2.0 L of air flow from a nebulizer
(Isotec 4, Avante Charolette, NC) driven by an oxygen concentrator (Pureline, Nidek Gamagori
Japan). For recordings of DA neurons, 1.5 g/kg urethane was injected IP. Body temperature was
maintained at 37.4 ± 0.4ºC by a feedback-regulated heating pad. With the skull exposed, a hole
was drilled for placement of a 3.0 M KCl-filled micropipette (2 to 4 MΩ; 1-2 µm inside diameter),
driven into the VTA with a piezoelectric microdrive (EXFO Burleigh 8200 controller and
Inchworm, Victor, NY) based on stereotaxic coordinates [from bregma: 5.6 to 6.5 posterior (P),
0.5 to 1.0 lateral (L), 6.5 to 9.0 ventral (V)]. Potentials were amplified with an Multiclamp 700A
amplifier (Axon Instruments, Molecular Devices, Union City, CA). Single-cell activity was
filtered at 0.3 to 10 kHz (3 dB) with the Multiclamp 700A amplifier and displayed on Tektronix
(Beaverton, OR) digital oscilloscopes. Potentials were sampled at 20 kHz (12 bit resolution) with
National Instruments (Austin, TX) data acquisition boards in Macintosh computers (Apple
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Computer, Cupertino, CA). Extracellularly recorded action potentials were discriminated with a
World Precision Instruments WP-121 Spike Discriminator (Sarasota, FL) and converted to
computer-level pulses. Single-unit potentials, discriminated spikes, and stimulation events were
captured by National Instruments NB-MIO-16 digital I ⁄O and counter ⁄ timer data acquisition
boards in Macintosh computers.
Characterization of VTA GABA and DA Neurons In vivo
VTA GABA and DA neurons were identified by previously-established stereotaxic coordinates
and by spontaneous electrophysiological and pharmacological criteria [43]. VTA GABA neuron
discharge activity characteristics included: relatively fast firing rate (>10Hz), ON-OFF phasic nonbursting activity, and an initially negative spike with duration less than 200 µsec. In some
experiments, GABA neurons were excited by DA (+40 nA) ejected iontophoretically from the
recording pipette [20, 21, 44]. Dopamine neurons were identified by relatively slow firing rate
(<10 Hz) and an initially positive-going spike of duration greater than 200 µsec. Most DA neurons
were inhibited by iontophoretic DA from the recording pipette. We evaluated only those spikes
that had greater than 5:1 signal-to-noise ratio. After positive neuron identification, baseline firing
rate was measured for 5 min to ensure stability prior to MStim.
Grass Stimulator and MStim for In-vivo Recordings
Following measurement of neuronal baseline firing rate, a 60 or 120 sec MStim was introduced.
The vibrating motor was controlled by a S44 Grass Stimulator (Grass Medical Instruments, West
Warwick, RI). For electrophysiological recordings, the stimulator was set at 3 V for 0.1 msec
duration and 0 msec delay [42]. Pulses/sec were varied to produce variations in vibrational
frequency. All vibratory stimuli were 60 or 120 sec in duration and followed by 15 min of
recording. Experimental groups included GABA neurons recordings following stimuli of 45, 80
and 115 Hz for both 60 and 120 sec with MStim given subcutaneously at the C7/T1 level, GABA
neurons recordings following 80 Hz, 120 sec stimuli (this combination resulted in the greatest
inhibition of GABA neuron firing rate and was used in all subsequent testing) given
subcutaneously at the right biceps femoris muscle and DA neuron recordings after 80 Hz, 120 sec
stimuli given subcutaneously at the C7/T1 level. Paired stimulation experiments were performed
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with the second stimulation 60 sec after GABA neuron firing rate returned to baseline following
the first stimulation.
Fast-Scan Cyclic Voltammetry
Evoked DA release in the NAc was measured by fast-scan cyclic voltammetry (FSCV) in vivo. A
7.0 μm diameter carbon fiber was inserted into borosilicate glass capillary tubing (1.2 mm o.d., AM Systems, Sequim, WA, USA) under negative pressure and subsequently pulled on a vertical
pipette puller (Narishige, East Meadow, NY, USA). The carbon fiber electrode (CFE) was cut
under microscopic control with 150~200 μm of bare fiber protruding from the end of the glass
micropipette. The CFE was back-filled with 3 M KCl. The electrode potential was linearly scanned
with a triangular waveform from −0.4 V to 1.3 V and back to −0.4 V versus Ag/AgCl using a scan
rate of 400 V/sec. Cyclic voltammograms were recorded at the CFE every 100 msec by means of
a ChemClamp voltage clamp amplifier (Dagan Corporation, Minneapolis, MN, USA).
Voltammetry recordings were performed and analyzed using customized software (Demon
Voltammetry) [45]. For in vivo voltammetry recordings of DA signals, rats were anesthetized with
2% isoflurane and placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA, USA).
Bipolar, coated stainless steel electrodes were stereotaxically implanted into the medial forebrain
bundle (MFB; −2.5 mm posterior, +1.9 mm lateral from bregma, −8.0 to −8.3 mm from skull), and
a capillary glass-based CFE in the NAc (+1.6 mm anterior, +1.9 mm lateral from bregma, −6.5 to
−8.0 mm from skull). The MFB was stimulated with 60 monophasic pulses at 60 Hz (4 msec pulse
width) at 2 min intervals until stable for five successive collections, defined as <10% variance.
Recordings were performed in 2 min intervals, with baseline preceding the post-vibratory (80 Hz,
120 sec) recordings. Recordings were performed for 120 min or until baseline was reached,
defined as 5 consecutive recordings at previously established baseline.

Microdialysis and High Performance Liquid Chromatography
Microdialysis probes (MD-2200, BASI) were stereotactically inserted into the NAc (+1.6 AP, +1.9
ML, -8.0 DV). Artificial cerebrospinal fluid (aCSF) composed of either 150 mM NaCl, 3 mM KCl,
1.4 mM CaCl2, and 0.8 mM MgCl2 in 10 mM phosphate buffer alone or, additionally, with either
10 nM naltrindole or a combination of 10 µM hexamethonium and 10 µM scopolamine was
perfused through the probe at a rate of 3.0 µl/min. Samples were collected every 20 min for 4 hr
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with MStim occurring after the first 2 hr had elapsed. Determination of the DA concentration in
microdialysis samples was performed using a HPLC pump (Ultimate 3000, Dionex, Sunnyvale,
CA, USA) connected to an electrochemical detector (Coulochem III, ESA). The detector included
a guard cell (5020, ESA) set at +270 mV, a screen electrode (5014B, ESA) set at -100 mV, and a
detection electrode (5014B, ESA) set at +220 mV. Dopamine was separated using a C18 reverse
phase column (HR-80, Thermo Fisher Scientific, Waltham, MA, USA). Mobile phase containing
75 mM H2NaO4P, 1.7 mM sodium octane sulfonate, 25 µM EDTA, 0.714 mM triethylamine, and
10% acetonitrile was pumped through the system at a flow rate of 0.5 ml/min.
Preparation of Brain Slices for Imaging and Confocal Microscopy
Rats were anesthetized using isoflurane and placed in a stereotaxic apparatus. Anesthesia was
maintained at 1.5% and motor was surgically implanted as described previously. MStim animals
were given 120 sec of 80 Hz stimulation. Control animals had motors surgically implanted but
not activated. After 2 hours animals underwent transcardial perfusion with 4% paraformaldehyde
(PFA). Once perfused, brains were carefully removed and placed in 4% PFA for 24 hrs to facilitate
continued fixation. After incubation in PFA, brains were placed in a solution of 30% sucrose in
1X PBS until the density of the brain matched that of the solution and the brains dropped to the
bottom of the vial (~24-48 hrs). Brains were then flash frozen in dry ice and mounted on a cold
microtome stage. Targeting the VTA and NAc, brains were sliced at 30 µm on the microtome and
slices were placed in cryoprotectant (30% ethylene glycol, 30% sucrose, 0.00002% sodium azide,
in 0.1 M PB) and kept at -20°C until staining. Slices were washed 3 times in 1x PBS for 10 minutes
on a rotator. They were then blocked with a blocking buffer comprised of 4% normal goat serum,
0.1% Triton-X 100 and 1x PBS. Slices were then washed another 3 times in 0.2% PBST on a
rotator. Primary antibodies were applied and allowed to incubate for 20 hours. Following staining
the slices were washed 3 times in 0.2% PBST and secondary antibodies were applied. After a 2 hr
incubation period they were washed another 3 times with 0.2% PBST and once with 1x PBS.
Antibodies included Mouse anti-tyrosine hydroxylase (Novus, 1:1328), Sheep anti-c-FOS
(Millipore, 1:1000) and Rabbit anti-DOR (LifeSpan, 1:200) as well as secondaries Alexa Fluor
405 Donkey Anti-Sheep from (1:900), Alexa Fluor 594 Goat anti-Rabbit (1:500). To mount slides,
sections were placed on microscope slides and dried ~5 min. Once dried, a drop of vectashield
(Vector Laboratories) was placed on the tissue, and a cover slip was placed on the slide. Slides set
48

overnight, and then they were kept at 4°C until imaging. An Olympus FluoView FV1000 confocal
microscope was used to image mounted slices. Brain slices were mounted on microscope slides
and imaged under oil immersion at 40X. To ensure consistent readings between samples, a
constant photomultiplier tube voltage and gain were set between all acquired images.
Data Collection and Statistical Analysis
For single-unit electrophysiology studies, discriminated spikes were processed with a spike
analyzer, digitized with National Instruments hardware and analyzed with National Instruments
LabVIEW and IGOR Pro software (Wavemetrics, Lake Oswego, OR). Extracellularly recorded
single-unit action potentials were discriminated by a peak detector digital processing LabVIEW
algorithm. Firing rate data was averaged across neurons at 10 sec intervals and subsequently
binned in 50 sec intervals for comparisons across time points. Experimental groups, in aggregate,
were compared to unstimulated neurons using a one-way ANOVA then corresponding bins were
compared with a Student’s t-test. Average depression or excitation in firing was calculated from
the point where firing rate deviated by >10% from baseline to the time it returned to within 10%
of baseline. Baseline firing rate was calculated from the average of the final 60 sec of firing rate
data before vibrational stimulus and after 5 min of recording to ensure neuron stability. The results
from all MStim and control groups were derived from calculations performed on ratemeter records
and expressed as means ± SEM.
For microdialysis, the area under the curve for the DA peak was extracted and a two-point
calibration was used to approximate the DA concentration. All collections were normalized to the
final baseline collection before the MStim occurred. Standard error for the final baseline collection
was approximated using the scalar property. Dopamine release for each timepoint following
MStim was then compared to the baseline control using a Dunnett’s analysis. Reverse
microdialysis and VTA injection experiments were compared to the MStim alone group using a
Student’s t-test at the 60 min time point.
For FSCV, evoked recordings were normalized to the established baseline within subjects and then
averaged across subjects in corresponding time intervals. Data was then binned in 10 min
intervals. Comparisons were made for each 10 min bin to control using a Dunnett’s analysis. All
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statistical tests were performed in JMP13 (SAS, Cary, NC). Figures were compiled using IGOR
Pro Software (Wavemetrics, Lake Oswego, OR).
For brain slice imaging, images were loaded into FIJI software. Images were duplicated to
preserve the original settings while color thresholding and brightness contrast adjustments were
made to determine the location of cells and create ROIs. ROIs were then projected back onto the
unedited images where area and mean intensity were recorded for each channel. This process was
performed by three independent raters blinded to the hypothesis. To determine relative density of
DORs, the ratio of mean fluorescence to area was determined.
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Results
MStim Modulation of VTA Neurons
The effects of MStim on VTA GABA neuron firing rate were tested across multiple stimulus
frequencies and durations (Fig. 3.1), as previously described[46]. MStim at 45 Hz (60 sec)
significantly inhibited GABA neuron firing rate when compared to unstimulated baseline firing
(F(1,277) = 24.9997, p<0.0001; Fig. 3.1A). GABA neuron firing rate was significantly reduced from
50 sec to 250 sec post-stimulus when compared to baseline (n=4; 50 sec, p=.0216; 100 sec,
p=.0460; 150 and 200 sec, p<.0001; 250 sec, p=.0222). Stimulation at 80 Hz (60 sec) (F(1,272) =
10.1423, p=0.0016; Fig. 3.1B) produced GABA inhibition similar to that produced by 45 Hz, with
significant depression from 100 to 250 sec post-stimulus (n=5; 100 sec, p=.0186; 150 and 200 sec,
p<.0001; 250 sec, p=.0101). MStim effects with the same frequencies at a duration of 120 sec are
shown in Fig. 3.1D-F. A 45 Hz stimulation (120 sec) significantly inhibited VTA GABA neurons
(F(1,282) = 15.2029, p=0.0001; Fig. 3.1D) similar to that observed with 60 sec MStim (n=5, 250
sec, p=.0032; 300 sec, p<.0001; 350 sec, p=.0434). The greatest inhibition to GABA neuron firing
rate occurred following application of 80 Hz (120 sec) MStim (F(1,296) = 114.0478, p<0.0001; Fig.
3.1E). Following this intervention, GABA neurons were significantly inhibited from 50 to 450 sec
post-stimulus (n=7, 50-350 sec and 450 sec, p<.0001; 400 sec, p=.0028). In contrast, both 60 and
120 sec of 115 Hz stimulation (Fig. 3.1C,F) did not produce a significant depression to GABA
neuron firing rate at any time point measured. Thus, GABA neuron firing was inhibited by MStim
in a differential and frequency-dependent manner.
Somatosensory mechanoreceptor density varies by topographical location, with greatest density in
the proximal joints and lower density in distal muscle [47, 48]. Therefore, to investigate differences
in anatomical application of the MStim, a location with a relatively smaller concentration of
mechanoreceptors was tested. Mechanical stimulation of 80 Hz (120 sec) at the belly of the right
biceps femoris muscle produced only a small erratic decrease in GABA neuron firing rate when
compared to the same stimulation at C7-T1 (F(1,421) = 146.4646, p<.0001; Fig. 3.2A). The two
were significantly different at 100-200 and 300 sec post-stimulus (n=4; 100 sec, p=.0137; 150 sec,
p=.0021), suggesting that MStim-dependent inhibition of VTA GABA firing is greatest at areas of
high mechanoreceptor density. Next, the effects of paired MStim was tested on VTA GABA firing
rate (Fig. 3.2B). . Compared to the second stimulation, the first typically produced greater
inhibition of VTA GABA firing rate (F(1,411) = 29.2118, p<.0001). Significant differences were
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noted at 100-200 sec and 300 sec (n=5; 100 sec, p=.0137; 150 sec, p=.0021; 200 sec, .0078; 300
sec, p=.0033). Thus, MStim-dependent inhibition of firing rate was repeatable, but sensitive to
desensitization-dependent processes. The 80 Hz (120 sec) stimulation produced the greatest effect
on GABA neuron firing rate and was used in all subsequent experiments.
Since the dogma is that VTA GABA neurons provide inhibitory input onto local DA neurons, the
effects of MStim on VTA DA neuron firing was tested. Dopamine neuron firing rate increased
significantly post-stimulus (F(1,429) = 246.4261, p<0.0001; Fig. 3.3A) reaching an average
maximum increase of 286% of baseline at 150 sec post-stimulus. Firing rate increased
significantly within the first 50 sec and stayed elevated to 500 sec post-stimulus. These times
points (50-500 sec post-stimulus) were all significant when compared to unstimulated baseline DA
neuron firing rate over time (n=5; 50-250 and 350-400 sec, p<.0001; 300 sec, p=.0026; 450 sec,
p=.0145; 500 sec, p=.0389; Fig. 3.3B). On average, following MStim, DA neurons increased
firing rate to 247% of baseline compared to 52.8 % inhibition observed in GABA neurons (Fig.
3.3C). The increase in DA neuron firing rate occurred in parallel to the reported decrease in GABA
neuron firing rate noted from the same stimulation paradigm, suggesting disinhibition of DA
neurons from decreased GABA neuron firing.
MStim Modulation of VTA Neurons: Role of NAc Projections and Endogenous Opioids
We have previously demonstrated that stimulation of the NAc inhibits VTA GABA neurons [43],
via direct pathway GABAergic medium spiny neurons, and that opiate effects on VTA GABA
neuron firing rate are mediated, in part, via GABA input to the VTA from the NAc [24]. To
determine if MStim modulation of VTA GABA neurons was in the VTA or via NAc input to the
VTA we evaluated the effects of in situ administration of the sodium channel blocker lidocaine
into the NAc on MStim effects on VTA GABA neuron firing rate. Inactivation of NAc neurons
by perfusion of lidocaine into the NAc via reverse microdialysis was sufficient to block MStiminduced depression of VTA GABA firing (F(1,416) = 264.9918, p<.0001; n=5; Fig. 3.4A). All time
points from 50-500 sec were significantly different (80 Hz 120 sec w/ lidocaine injection in NAc,
n=5; 80 Hz 120 sec, n=7; 50 sec, p<.0001; 100 sec, p<.0001; 150 sec, p<.0001; 200 sec, p<.0001;
250 sec, p<.0001; 300 sec, p<.0001; 350 sec, p=.0005; 400 sec, p<.0001; 450 sec, p<.0001; 500
sec, p<.0001). We have previously shown that stimulation of the HT7 acupoint inhibits VTA
GABA neuron firing rate, which is blocked by systemic administration of the non-selective opioid
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receptor (OR) antagonist naloxone and the delta OR (DOR) antagonist naltrindole [38]. To better
understand the role that DORs play in the underlying mechanisms responsible for the reported
mesolimbic effects of MStim, the 80 Hz (120 sec) stimulation experiments were repeated while
recording from GABA neurons in the VTA. First, systemic pretreatment with naltrindole (1 mg/kg
IP), 15 min prior to MStim precluded the depression of GABA neuron firing rate (F(1,487) =
190.4457, p<.0001; n=4; Fig. 3.4A,B). The depression was blocked at every time point that was
previously significant when comparing the 80 Hz stimulus to unstimulated baseline recordings in
GABA neurons. The differences between 80 Hz w/ naltrindole and 80 Hz alone were pronounced
and noted at all time points from 50-500 sec (80 Hz 120 sec w/ naltrindole, n=4; 80 Hz 120 sec,
n=7; 50 sec, p<.0001; 100 sec, p<.0001; 150 sec, p<.0001; 200 sec, p<.0001; 250 sec, p<.0001;
300 sec, p<.0001; 350 sec, p=.0017; 400 sec, p=.0101; 450 sec, p=.0002; 500 sec, p<.0001).
MStim Enhancement of Dopamine Release: Role of Endogenous Opioids
To determine if MStim-induced changes in DA firing might translate to an increase in DA
neurotransmission, microdialysis and voltammetry experiments were performed on basal and
evoked DA release in the NAc, respectively. Microdialysis experiments revealed an increase in
basal release, with greatest release occurring from 40 – 60 min (178.43 ± 26.24% of baseline),
after MStim (n=15; 60 min, Dunnett’s, p=.016; Fig. 3.5A). From 80 to 120 min post-stimulus,
DA levels returned to baseline levels and stabilized. Next, voltammetry experiments were used to
measure rapid changes in electrically evoked DA release. Evoked DA release rose slightly faster
than basal release with significant increases 10 min post-stimulus (Fig. 3.5B). Increased levels of
evoked DA release were significantly maintained from 10-50 min, peaking at 40 min (135.03 ±
23.13% of baseline), with a return to baseline levels at 60 min (n=4; Dunnett’s 10 min, p=.0176;
20 min, p=.0053; 30 min, p=.0781; 40 min, p=.0006; 50 min, p=.0023). Thus, MStim produces
increases in DA levels.
We then evaluated the role of endogenous opioids in mediating MStim-induced enhancement of
DA release in the NAc. To determine the site specificity of the DORs involved in the effect (VTA
versus NAc) we administered an ipsilateral injection of naltrindole into the VTA 15 min prior to
stimulation and found unexpectedly that it did not attenuate MStim-induced DA release in the NAc
(n=15, MStim alone; n=4, VTA naltrindole; p=0.570). Next, to determine whether local
antagonism of NAc DORs contributes to MStim induced increases in DA release, we applied
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naltrindole via reverse microdialysis (10 nM) in the NAc prior to MStim at the cervical spine (Fig.
3.6A). Local application of naltrindole blocked the MStim-induced increase in DA release in the
NAc at the 60 min time point from 178.43 ± 26.24% of baseline in the MStim alone group to 88.0
± 9.31% of baseline (n=15, MStim alone; n=8, naltrindole NAc; p=.0096; Fig. 3.6B). As sensorydriven cholinergic interneurons (CINs) in the NAc express DORs and have been shown to
influence local DA release [49, 50], a combination of hexamethonium (10µM) and scopolamine
(10µM) was then administered to the NAc via reverse microdialysis to evaluate the role of local
acetylcholine (ACh) release on MStim induced DA release (Fig. 3.6A). At the 60 min time point
DA release increased to 107.62 ± 3.4 % of baseline which represents significant attenuation of the
MStim induced DA increase when compared to the MStim alone group (n=15, MStim alone; n=8,
Hex/Scop NAc; p=.0311; Fig. 3.6B). These data suggest that the MStim-induced increase in DA
release in the NAc is mediated through endogenous activation of DORs in the NAc and not the
VTA and that the effect is in part influenced by local release of Ach from CINs.
MStim Activation of NAc Neurons
To further evaluate neuronal activation changes in the NAc and VTA and alterations in DOR
expression in the NAc following MStim, post-MStim brain slices were stained to evaluate changes
in relative expression of DORs and c-FOS. The number of cells per slide expressing DORs in the
NAc was significantly increased in the MStim group when compared to control (F(1,11) = 10.6,
p=0.008; n=6; Fig. 3.7A,B,E). c-FOS expression in the NAc and VTA was analyzed for mean
number of cell counts and mean fluorescent intensity (MFI). There was an increase in the number
of cells expressing c-FOS in the NAc following MStim (53.0 ± 6.29) when compared to control
(33.83 ± 6.79; p=0.0314, n=6), but not in the VTA (50.50 ± 2.94 vs 65.83 ± 9.36 cells; p=0.0847;
Fig. 3.7C). However, when considering c-FOS MFI, there was a decrease in c-FOS expression in
the VTA with MStim (109.6 ± 0.9% vs 116.8 ± 1.2%; p=0.0071, n=6; Fig. 3.7D), but not in the
NAc. Together, these data suggest that the decrease in VTA c-FOS expression following MStim
is likely due to enhanced inhibitory projections from the NAc.
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Discussion
In this study, pathway specific experiments were performed to better understand the role of MStim
in natural reward pathways. Low to high frequency (45-80 Hz) MStim produced robust inhibition
of VTA GABA neurons. This was not surprising given our previous reports regarding
mechanoreceptor-mediated inhibition of VTA GABA neurons [38, 42]. However, here we
demonstrated that decreases in VTA GABA neuron firing by MStim are frequency, location, and
time-dependent, and are accompanied by concomitant increases in VTA DA cell firing, increases
in DA release in the NAc and mediation by endogenous opioid and local ACh release in the NAc.
The three frequencies tested were chosen to target specific mechanoreceptors. Of those chosen,
45 Hz enlists mostly Meissner’s corpuscles [51, 52], while 115 Hz is more selective for Pacinian
corpuscles [53, 54]. Both receptors are subcutaneously located. The frequency of 80 Hz lies
between the two and likely activates both receptors. Additionally, all three frequencies can activate
Ruffini endings and Golgi tendon organs, two receptors that are morphologically similar to one
another and are important as joint mechanoreceptors [55-57]. The 50 and 80 Hz MStim produced
a transient depression of GABA neurons in the VTA, with 80 Hz (120 sec) producing the largest
and longest lasting effect. Importantly, 80 Hz MStim failed to achieve a meaningful depression in
VTA GABA neuron firing rate when applied at the belly of the biceps femoris muscle. This midmuscle location was chosen because of its distance from joints and subsequent lower concentration
of mechanoreceptors relative to the cervical spine [47, 48, 54]. Given that 80 Hz produced the
greatest inhibition, 115 Hz failed to elicit a response and that the mid-muscle stimulation was
ineffective at 80 Hz, suggesting a role for deep joint mechanoreceptors and Meissner’s corpuscle
dependent pathways as main mediators of the resultant GABA depression. Taken together, these
data suggest that the noted effects are only anatomically specific insomuch as anatomical location
relates to the potential for mechanoreceptor recruitment. Even dorsal root ganglion cell bodies
have been shown to depolarize in response to mechanical stimulation [58], perhaps enhancing the
effects noted from stimulation to spine. It is also worth noting that subcutaneous stimulation
provided in this study to the cervical spine is likely to have impacted most of the cervical and some
of the thoracic spine, increasing the number of cutaneous and joint receptors activated. To our
knowledge, this is the first evidence demonstrating that localized MStim increases DA neuron
firing rate in the VTA and increases DA release in the NAc. Mechanical stimulation at 80 Hz (120
sec) elicited DA neuron firing of 247% baseline that occurred simultaneous to the average
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depression of GABA neurons to 52.8% of baseline (Fig. 3.3C). This relationship suggests
a disinhibition of DA neurons by way of GABA neuron depression.
Though previous studies have implicated DORs in the mechanoacupuncture-elicited depression of
VTA GABA neurons [38], the location of DORs (spinal versus mesolimbic) has not been
described. The present results suggest that mechanoreceptor stimulation results in increases in
endogenous opioid release leading to transient modulation to the mesolimbic circuitry. There is a
precedence for frequency-dependent release of endogenous opioids. For instance, in rats tolerant
to morphine, low frequency (1-15 Hz) transcutaneous electrical nerve stimulation (TENS) was less
effective than placebo controls at reducing joint inflammation, suggesting that TENS-alleviated
joint inflammation is opioid dependent [59, 60]. Also, the effects of low frequency, but not high
frequency, TENS stimulation are blocked by application of naloxone at doses selective for mu
opioid receptors (MORs) and sparing of DORs and KORs [61]. Conversely, administration of the
selective DOR antagonist naltrindole blocks the effects of high frequency TENS but spares those
of a similar low frequency stimulation, though this effect appears to be isolated to spinal circuits
[61]. While KORs have been shown on both cell bodies and terminals of DA neurons, MORs and
DORs are absent [62]. However, DORs are located on synaptic terminals of GABA neurons in
the VTA and NAc [62] and, of particular relevance to this study, on CINs in the NAc[63]. Delta
opioid receptors are located in both the VTA and NAc [64, 65] and systemic (IP) administration
of naltrindole blocked MStim effects on VTA neuron firing rate and DA release in the NAc.
Interestingly, MStim-induced increase in NAc DA release was attenuated by selective blockade of
DORs with naltrindole in the NAc but not the VTA. Corroboration of the VTA effects being
driven by activity in the NAc was confirmed when MStim-induced VTA GABA neuron depression
was blocked by local administration of lidocaine into the NAc. In light of the receptor distribution,
the site-specific effect of DOR antagonists, the attenuation by NAc lidocaine application, the
disparate expression of c-FOS in the NAc and VTA and the congruity of GABA depression and
DA excitation (Fig. 3.4C), these data suggest that VTA effects are mainly due to NAc to VTA
projections.
Voltammetry data shows a fast increase in evoked release that returns to baseline within 60 min
while microdialysis shows a more gradual increase, peaking around 60 min post-stimulus (Fig.
3.5A and 3.5B). Interestingly, because GABA and DA neuron firing rates returned to baseline
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after 464.3and 366.7 sec post-stimulus, respectively, it is apparent that other factors influence the
elevation in DA release, allowing release levels to remain elevated after VTA neuron firing rate
has returned to baseline. This coupled with the fact that DA release was attenuated by blockade of
both cholinergic and DORs in the NAc but not the VTA suggests that local factors related to DA
terminals are the main drivers of MStim-induced DA release. One factor that needs careful
consideration in the timing and mechanisms underlying MStim-induced DA increases are the
multiple converging pathways onto the mesolimbic DA system (both in somatic and distal axonic
regions). Dopamine terminals can be modulated independently of activity in cell body regions
[49]. Specifically, sensory thalamic projections activate striatal CINs, which drive DA release
through nicotinic acetylcholine (ACh) receptor activation. Further, accumbal DA release has been
shown to increase with administration of DPDPE, a DOR agonist, in a dose-dependent manner
with the effects lasting around 60 min in vivo when measured with microdialysis [66]. Therefore,
it is also possible that MStim induces striatal release onto local DORs to further enhance DA
release, as suggested by the near total blockage of MStim-induced DA release with NAc
application of naltrindole. In the striatum, DORs exhibit increased levels of membrane
translocation on CINs in response to acute cocaine administration, learning events and by
activation of D1 receptors [67, 68]. This is particularly relevant considering the increased DOR
translocation caused by MStim in the NAc. Activation of DORs on striatal CINs can induce
hyperpolarization-activated currents that results in burst firing of CINs[67, 69], which can, in turn,
lead to further release of DA by activation of ACh receptors located on DA terminals. As
previously noted, MStim effects on VTA GABA neurons are likely secondary to MStim effects in
the NAc and changes in DA release are likely through changes in CIN circuit effects, local
activation of DORs and reciprocal projections from the NAc to VTA. It is also unknown if other
non-GABA effects are contributing to MStim-induced increases in DA release.
Mechanoreceptors remain some of the least understood physiologic receptors, especially noncanonical activation effects on central processes including modulation of neurons in sub-cortical
structures like the midbrain. Even some basic aspects of their methods of signal transduction and
pathways recruited remain elusive. In spite of this, it is becoming increasingly evident that
mechanoreceptors play a broader role than simply as somatosensory relay devices [1-4]. Here we
begin exploration of their effects on mesolimbic circuitry. The mesolimbic DA system is a
therapeutic target of treatments for a myriad of conditions including depression, ADHD, eating
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disorders, Parkinson’s and addiction and there is a pressing need for new treatments to serve as
adjuncts to current pharmacological approaches. Future studies should explore the possibility that
practitioners of manual medicine, chiropractic physicians, acupuncturists, and physical therapists,
might play in the development and implementation of adjunctive treatments for drug-abuse
disorders. It remains to be seen if specific application of MStim therapy can alter drug-seeking
behavior, which we are currently pursuing. Further, though these findings are specific to neurons
in one circuit, they open the possibility that translational findings in other brain regions could lead
to novel applications for mechanoreceptor-based therapies.
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Figure Legends
Figure 3.1 – Frequency and duration-dependent effects of MStim on VTA GABA neuron firing
rate.
(A-C) Summarized time course data for 45 (A), 80 (B) and 115 Hz (C) stimulation at 60 sec
duration. Representative ratemeter recordings of VTA GABA neurons are shown on the left and
summarized data on the right. Note that 45 and 80 Hz MStim significantly inhibited the firing rate
of VTA GABA neurons while 115 Hz had no effect. (D-F) The same set of frequency responses,
but with a 120 sec stimulation. Note that 45 and 80 Hz MStim significantly inhibited VTA GABA
neuron firing rate while 115 Hz had no effect, and that the inhibition was more pronounced with
longer MStim durations. Asterisks *,**,*** indicate significance levels p<0.05, 0.01 and 0.001,
respectively.
Figure 3.2 – Spatiotemporal variation in MStim-induced effects on VTA GABA neuron firing
rate.
(A) VTA GABA neuron response to MStim (80 Hz; 120 sec) at the right biceps femoris muscle
belly compared to cervical spine at C7-T1. Note that MStim at the biceps femoris was without
effect on VTA GABA neuron firing rate. (B) VTA GABA neuron response to MStim at the C7T1 vertebral level by two subsequent stimuli. Note the diminution in VTA GABA neuron firing
rate with the second 80 Hz, 120 sec stimulation compared to the first. Asterisks *,**,*** indicate
significance levels p<0.05, 0.01 and 0.001, respectively.
Figure 3.3 – Dopamine neuron response to MStim.
(A) Representative trace of DA neuron firing rate in response to MStim (80 Hz; 120 sec). Note
that MStim markedly increased the firing rate of this VTA DA neuron. (B) Summarized time
course comparing VTA DA neuron firing rate to MStim vs an unstimulated baseline. (C)
Dopamine neuron firing rate changes compared to time-equivalent GABA neuron firing rate
changes in response to MStim. (D) Summarized data comparing average firing rate changes in
VTA neurons by MStim. Values in parentheses are n values. Asterisks *,**,*** indicate
significance levels p<0.05, 0.01 and 0.001, respectively.
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Figure 3.4 – Role of NAc inputs to the VTA and endogenous opioids in MStim-induced inhibition
of VTA GABA neuron firing rate.
(A,B) Local injection of lidocaine into the NAc and IP administration of the DOR antagonist
naltrindole blocked MStim-induced inhibition of VTA GABA neuron firing rate (80 Hz; 120 sec).
Values in parentheses are n values. Asterisks *,**,*** indicate significance levels p<0.05, 0.01
and 0.001, respectively.
Figure 3.5 – MStim effects on basal and evoked DA release in the NAc.
(A) MStim enhanced basal DA release in the NAc, as measured by microdialysis. (B)
Representative, superimposed voltammograms showing oxidation/reduction current vs voltage
plots comparing DA release during baseline vs MStim. (C) Representative, superimposed current
vs time plots showing DA release associated with local electrical stimulation. Calibration bars are
nA and seconds. (D) MStim also enhanced evoked DA release in the NAc, as measured by
voltammetry. Asterisks *,**,*** indicate significance levels p<0.05, 0.01 and 0.001, respectively.
Figure 3.6 – Role of DORs and CINs in MStim-induced enhancement of DA release in the NAc.
(A) Summarized time course of in situ NAc naltrindole or hexamethonium/scopolamine effects on
MStim-induced enhancement of basal DA release in the NAc (80 Hz; 120 sec). Note that
naltrindole or hexamethonium/scopolamine infusion into the NAc blocked MStim-induced
enhancement of basal DA release. (B) Summarized data at the 60-min time point. Values in
parentheses are n values. Asterisks *,**,*** indicate significance levels p<0.05, 0.01, and 0.001,
respectively.
Figure 3.7 – MStim activates neurons and induces translocation of DORs in the NAc.
(A,B) Increased expression of DORs (red; TH is blue) in the NAc 2-hours post MStim compared
to control. Insets show magnified views at point on 40X image indicated by the *. Note the
translocation of DORs to the cell membrane. (C) Increased number of neurons in the NAc, but not
the VTA, expressing c-FOS 2 hrs post MStim. (D) Decreased expression of c-FOS mean
fluorescent intensity (MFI) in the VTA, but not in the NAc, 2 hrs post MStim. (E) Total number
of NAc cells expressing DORs 2 hrs post MStim. Values in parentheses are n values. Asterisks
*,** indicate significance levels p<0.05 and 0.01, respectively.
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Abstract
Mechanical stimulation (MStim) has been previously shown in modulate firing rate of neurons in
the ventral tegmental area (VTA) and dopamine (DA) release in the nucleus accumbens (NAc), an
area of interest in alcohol-use disorder (AUD). In this study we examine the effects of MStim,
during chronic alcohol dependence, on neurons in VTA and NAc and behavioral measures during
withdrawal. We show that when MStim is administered concurrently with alcohol, it alters alcoholinduced desensitization of VTA GABA neuron firing rate in response to a reinstatement dose from
117.5 % of baseline to 32.3 %. Dopamine release in the NAc at 120 min post-injection is changed
from 119.8 % of baseline to 70.1 %. Further, behavioral indices of withdrawal (rearing, open-field
crosses, tail stiffness and gait) were substantively ameliorated with treatment with MStim
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Introduction
Alcohol addiction is a chronic relapsing disease that affects more Americans than all forms of
cancer combined (SAMHSA, 2016). It leads to destructive psychological, physical, social, and
economic consequences. It is estimated that over 28 million Americans are currently in need of
treatment for alcohol abuse, resulting in over $249 billion in direct costs (Sacks et al., 2015).
Making matters worse, only 13% of those needing intervention actually receive it. Further, in spite
of the wonderful advances in our understanding of the neuropathophysiology of addiction, the
success rate of treatment has not substantively changed over the last hundred years, with around
50% of those treated relapsing (Moos and Moos, 2006; White, 2012; SAMHSA, 2016). This
represents approximately 6% of those suffering from the disease receiving effective treatment. A
report ranking the different conditions relative to the “global burden of disease” found that ethanol
ranked 3rd out of the 25 major contributors (Lim et al., 2012).
The current FDA-approved treatments for AUD are the sensitizing agent disulfiram, the muopioid receptor (MOR) antagonist naltrexone, and the neuromodulatory balancing agent
acamprosate (Akbar et al., 2018). Many consider these pharmacological treatments to be woefully
inadequate, and the public is begging for more efficacious treatments for AUD. Many are seeking
alternative, non-invasive, non-pharmacological alternatives as personalized care and as adjuncts
to self-help programs. Thus, more fundamental science and novel methods are needed to determine
mechanisms underlying alternative approaches and improve outcomes.
The use of mechanoreceptor-based therapies (MStim) in the treatment of drug-abuse disorders is
a largely unexplored field. Notably, several complementary health care approaches are thought to
have effects mediated in part by activation of mechanoreceptors, including chiropractic medicine,
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acupuncture, and physical therapy. There is compelling evidence suggesting that some of the
benefits ascribed to acupuncture are mediated, through somatosensory neuronal pathways shared
with MStim. We have shown in multiple reports that stimulation of the HT7 acupoint modifies
drug-seeking behaviors and relapse to cocaine (Yoon et al., 2012; Jin et al., 2018),
methamphetamine (Kim et al., 2019), and ethanol (Yang et al., 2010). These effects can be
attenuated with ablation of the dorsal column/medial lemniscal pathway and appear to act through
endogenous opioids (Yang et al., 2008; Kim et al., 2013; Chang et al., 2017). Though these studies
demonstrate anatomically site-specific effects, they are suggestive that activation of primary
somatosensory fibers generally may attenuate the reinforcing effects of drugs of abuse.
We have previously reported that MStim at 80 Hz to the cervical spine inhibits VTA GABA neuron
firing, enhances VTA DA neuron firing and increases DA release in the NAc. Further, we have
shown that VTA effects are driven by cholinergic interneurons (CIN) and delta opioid receptors
(DOR) in the NAc. These findings are salient considering the role that the mesolimbic circuitry
plays in reward, dependence and withdrawal. Midbrain dopamine (DA) neuron activity is involved
in many aspects of reward seeking (Dalle Grave et al., 2008; Ranaldi, 2014; Gentry et al., 2018).
Although the prevailing dogma is that DA neurons mediate the rewarding and addictive properties
of drugs of abuse (Wise, 2008), VTA GABA neurons have garnered much interest for their role in
modulating DA release and perhaps as independent substrates mediating reward or aversion
(Gallegos et al., 1999; Stobbs et al., 2004; Steffensen et al., 2008; Ludlow et al., 2009; Steffensen
et al., 2009; Brown et al., 2012; Tan et al., 2012). We have shown previously that acute
administration of ethanol, opioids, or cocaine inhibits VTA GABA neurons (Gallegos et al., 1999;
Stobbs et al., 2004; Steffensen et al., 2006; Steffensen et al., 2008; Ludlow et al., 2009; Steffensen
et al., 2009), leading to a net disinhibition of VTA DA neurons (Carboni et al., 1989; Yoshimoto
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et al., 1992; Bocklisch et al., 2013). In contrast, during ethanol or opioid withdrawal, VTA GABA
neurons become hyperactive (Bonci and Williams, 1997; Gallegos et al., 1999) leading to
decreased mesolimbic DA activity and release in the NAc (Maisonneuve et al., 1995; Koeltzow
and White, 2003; Wise, 2004; Karkhanis et al., 2016; Rose et al., 2016). This reduction in
mesolimbic DA transmission is theorized to be the primary driver of relapse (Lyness and Smith,
1992).
In this study, we investigate the role of MStim as a potential treatment for ethanol-use disorder by
evaluating its ability to ameliorate chronic ethanol-induced changes to VTA GABA neuron firing,
DA release in the NAc and behavioral indices related to withdrawal. We hypothesized that MStim
is sufficient to block chronic ethanol-induced desensitization of VTA GABA neurons and changes
in NAc DA release in response to ethanol reinstatement. Further, that MStim would block anxietyrelated behaviors normally associated with chronic ethanol withdrawal.

Materials and Methods
Animals and MStim Motor Implantation
Male wistar rats, weighing 250-320 g, from our breeding colony at Brigham Young University
were used. Rats were housed in groups of 2-3 at a fixed temperature (21-23°C) and humidity (5565%) on a reverse light/dark cycle with ad libitum food and water. Rats were briefly anesthetized
using isoflurane (4.0%) during injections to mitigate injection stress. Each received BID IP
injections (9 am and 5 pm) of ethanol (2.5g/Kg; 16% w/v) or saline for 14-days. Intoxication was
verified visually by noting loss of consciousness following initial injections with increasing
tolerance. Immediately following injections MStim rats were placed on a LabWorks Inc ET-126
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shaker device (Alpine, UT) with a sheet of 1/4 inch, 18 in x 18 in plexiglass fastened atop for 15min. An 80 Hz, 500 mVpp sine wave was generated using a Wavetex Datron Universal Waveform
Generator model 195 (San Diego, CA) and amplified using a Crown model XLi 3500 (Los
Angeles, CA) amplifier. All animal received a final injection at 9am and were tested at 9am the
following day. Experimental protocols were approved by the Brigham Young University
Institutional Animal Care and Use Committee according to NIH guidelines.

Single Cell Electrophysiology
For recordings of VTA GABA neurons, rats were anesthetized using isoflurane and placed in a
stereotaxic apparatus. Anesthesia was maintained at 1.5% with 2.0 L of air flow from a nebulizer
driven by an oxygen concentrator. Body temperature was maintained at 37.4 ± 0.4ºC by a feedback
regulated heating pad. With the skull exposed, a hole was drilled for placement of a 3.0 M KClfilled micropipette (2 to 4 MΩ; 1-2 µm inside diameter), driven into the VTA with a piezoelectric
microdrive (EXFO Burleigh 8200 controller and Inchworm, Victor, NY) based on stereotaxic
coordinates [from bregma: 5.6 to 6.5 posterior (P), 0.5 to 1.0 lateral (L), 6.5 to 9.0 ventral (V)].
Potentials were amplified with an Axon Instruments Multiclamp 700A amplifier (Union City, CA).
Single-cell activity was filtered at 0.3 to 10 kHz (3 dB) with the Multiclamp 700A amplifier and
displayed on Tektronix (Beaverton, OR) digital oscilloscopes. Potentials were sampled at 20 kHz
(12 bit resolution) with National Instruments (Austin, TX) data acquisition boards in Macintosh
computers (Apple Computer, Cupertino, CA). Extracellularly recorded action potentials were
discriminated with a World Precision Instruments WP-121 Spike Discriminator (Sarasota, FL) and
converted to computer-level pulses. Single-unit potentials, discriminated spikes, and stimulation
events were captured by National Instruments NB-MIO-16 digital I ⁄O and counter ⁄ timer data
acquisition boards in Macintosh computers.
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Characterization of VTA GABA
VTA GABA neurons were identified by previously-established stereotaxic coordinates and by
spontaneous electrophysiological and pharmacological criteria (Steffensen et al., 1998). VTA
GABA neuron discharge activity characteristics included: relatively fast firing rate (>10Hz), ONOFF phasic non-bursting activity, and an initially negative spike with duration less than 200 µsec.
GABA neurons were excited by iontophoretic DA (+40 nA) ejected from the recording pipette. .
We evaluated only those spikes that had greater than 5:1 signal-to-noise ratio. After positive
neuron identification, baseline firing rate was measured for 5 min to ensure stability prior to
MStim.

Grass Stimulator and MStim for in-vivo Recordings
Following measurement of neuronal baseline firing rate, a 60 or 120 sec MStim was introduced.
The vibrating motor was controlled by a S44 Grass Stimulator (Grass Medical Instruments, West
Warwick, RI). For electrophysiological recordings, the stimulator was set at 3 V for 0.1 msec
duration, 0 msec delay and 80 pulses/sec (Bills et al., 2019). All vibratory stimuli were 120 sec in
duration and followed by 60 min of recording.

Microdialysis and High Performance Liquid Chromatography
Microdialysis probes (MD-2200, BASI) were stereotactically inserted into the NAc (+1.6 AP, +1.9
ML, -8.0 DV). Artificial cerebrospinal fluid (aCSF) composed of 150 mM NaCl, 3 mM KCl, 1.4
mM CaCl2, and 0.8 mM MgCl2 in 10 mM phosphate buffer was perfused through the probe at a
rate of 3.0 µl/min. Samples were collected every 20 min for 4 hr with MStim occurring after the
first 2 hr had elapsed. Determination of the DA concentration in microdialysis samples was
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performed using a HPLC pump (Ultimate 3000, Dionex, Sunnyvale, CA, USA) connected to an
electrochemical detector (Coulochem III, ESA). The detector included a guard cell (5020, ESA)
set at +270 mV, a screen electrode (5014B, ESA) set at -100 mV, and a detection electrode (5014B,
ESA) set at +220 mV. Dopamine was separated using a C18 reverse phase column (HR-80,
Thermo Fisher Scientific, Waltham, MA, USA). Mobile phase containing 75 mM H2NaO4P, 1.7
mM sodium octane sulfonate, 25 µM EDTA, 0.714 mM triethylamine, and 10% acetonitrile was
pumped through the system at a flow rate of 0.5 ml/min.

Behavioral Measures of Withdrawal
Behavioral experiments were performed in a 16 T × 16 W × 32 L inch light attenuating plexiglass
compartment and were recorded using a camera mounted on the ceiling above the apparatus
connected to a Windows 7 PC running Pinnacle Studio 16 (Corel, Menlo Park, CA, USA). On
test days, withdrawal rats were placed in the center of the chamber and visually inspected and
subjectively scored for gait and tail stiffness. Each rat was scored twice by different raters blinded
to the rat’s experimental condition to reduce bias. The two scores were averaged. Tail stiffness
was scored 1-5 (1-no stiffness; 2-minor stiffness with no tail elevation with ambulation; 3-minor
stiffness with elevation during ambulation; 4-moderate stiffness with elevation at rest; 5- severe
stiffness with elevation at all times). Gait was scored 1-5 (1-normal movement pattern with no
hunching at rest or during ambulation; 2-normal movement patterns with mild hunching at rest but
not during ambulation; 3-abnormal movement patterns with mild hunching at rest but not during
ambulation; 4-abnormal movement patterns with moderate to severe hunching at rest but not suring
ambulation; 5-abnormal movement patterns with severe hunching at rest and during ambulation).
Open-field crosses were defined as the number of times the animal crossed through the middle 1/3
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of the chamber and rears were defined as independent instances of both front paws leaving the
ground and being elevated above resting head level.

Data Collection and Statistical Analysis
For single-unit electrophysiology studies, discriminated spikes were processed with a spike
analyzer, digitized with National Instruments hardware and analyzed with National Instruments
LabVIEW and IGOR Pro software (Wavemetrics, Lake Oswego, OR). Extracellularly recorded
single-unit action potentials were discriminated by a peak detector digital processing LabVIEW
algorithm and recorded in 10 sec intervals. Firing rate data was averaged across neurons at 10 sec
intervals and subsequently binned in 50 sec intervals for comparisons across time points as
previously reported (Bills, 2019). Experimental groups were averaged across bins and then
compared using a one-way ANOVA then corresponding bins were compared with a Student’s ttest. Average depression or excitation in firing was calculated from 10-40 min post injection.
Baseline firing rate was calculated from the average of the final 60 sec of firing rate data before
vibrational stimulus and after 5 min of recording to ensure neuron stability. The results from all
MStim and control groups were derived from calculations performed on ratemeter records and
expressed as means ± SEM.
For microdialysis, the area under the curve for the DA peak was extracted and a two-point
calibration was used to approximate the DA concentration. All collections were normalized to the
final baseline collection before injection occurred. Standard error for the final baseline collection
was approximated using the scalar property. Dopamine release for each time point was expressed
as a percentages of baseline ± SEM. They were compared using a one-way ANOVA after which
the groups were compared using a Tukey’s posthoc analysis.
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For behavioral experiments, after blinded scoring, results were compared using a one-way
ANOVA after which groups were compared using a Tukey’s posthoc analysis.

Results
Amelioration of chronic ethanol-induced changes to VTA GABA neurons by MStim
The effects of concurrent administration of 80 Hz MStim during chronic EtOH exposure were
tested on VTA GABA neuron firing rate in the context of a reinstatement dose of EtOH (2.5g/kg
IP) (Fig. 4.1). Baseline firing rate of GABA neurons in animals chronically exposed to EtOH was
significantly higher (49.59 Hz) than that of animals that received concurrent MStim or saline
with MStim (30.02 Hz and 35.94 Hz respectively) (F(2,11) = 5.1149, p=0.0269; Fig. 4.1D).
Mechanical stimulation produced altered GABA neuron response to reinstatement EtOH when
compared to chronic EtOH and saline groups (F(2,108) = 1348.799, p<0.0001; Fig. 4.1E)
Administration of 2.5g/kg IP reinstatement dose of EtOH in chronically exposed animals
produced a slight increase in average GABA neuron firing to 117.52% (±0.039, n=5) of
baseline. The same injection in MStim treated animals caused a decrease in firing to 32.72%
(±0.043, n=5) of baseline while in saline treated rats it produced a drop to 14.71% (±0.050,
n=5) of baseline. All groups were significantly different from each other (EtOH and MStim,
p<0.0001; EtOH and Sal, p<0.0001; Sal and MStim, p<0.0001; Fig. 4.1F). between MStim and
saline groups (p=0.046). Thus, MStim, when given concurrently with chronic intermittent
EtOH exposure to 2.5g/kg EtOH, blocks chronic EtOH-induced desensitization of VTA
GABA neurons to reinstatement exposure.

MStim effects on chronic ethanol-induced changes to NAc DA release
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To determine if blockage of chronic EtOH-induced changes to VTA GABA neuron firing rate by
MStim translates to alterations in DA release in the NAc, dialysate samples were collected by
microdialysis canula before and after a reinstatement dose of EtOH was given to rats after 24 hours
of withdrawal (Fig. 4.2). Groups tested included a group naïve to both MStim and EtOH, EtOH,
EtOH with MStim and saline with MStim. Animals naïve to both EtOH and MStim exhibited a
rise in DA levels from 20 min to 120 min post-injection and significant differences were noted
between the groups at those times (20 min, F(3,13) = 6.0631, p=0.0082; 40 min, F(3,13) = 3.4890,
p=0.0471; 60 min, F(3,13) = 3.8812, p=0.0368; 80 min, F(3,13) = 5.0333, p=0.0157; 100 min, F(3,13)
= 7.8089, p=0.0023; 120 min, F(3,13) = 5.5628, p=0.0091; Fig. 4.2A). Specific differences between
groups were noted at min 20 between naïve and MStim groups (naïve n=8, MStim n=3, p=0.0345),
at min 100 between naïve and MStim and naïve and saline groups (naïve n=8, MStim n=3,
p=0.0071; saline n=3, p=0.0147) and at min 120 between naïve and saline groups (p=0.0135).
Initial responses to ethanol reinstatement was uniform between the three experimentally exposed
groups with DA levels demonstrating parity from minutes 20-80. At 100 minutes post-injection
the EtOH group diverged from the other two measuring 95.42 % (±4.78) of baseline, closer to the
naïve group which measured 119.99 % (±8.77).At this same timepoint the MStim and saline
groups measured 57.61 % (±11.48) and 66.89 % (±16.78) respectively (Fig. 4.2B). At 120 min
post-injection dopamine levels in the EtOH group elevated past baseline levels to 120.27 %
(±10.28). which was in-line with the naïve response at 113.36 % (±5.91). Mechanostim and saline
groups remained lower at 69.48 % (±13.16) and 47.90 % (±11.11) respectively. This is suggestive
that MStim treatment alters DA release in response to ethanol in both previously exposed and
unexposed animals.
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MStim blocks withdrawal symptoms in rats exposed to chronic EtOH
To assess the behavioral relevance of MStim on indices of chronic EtOH withdrawal, rats in active
withdrawal (24 hours after last dose) were evaluated for open field crosses, rearing behavior, tail
stiffness and gait patterns (Fig. 4.3). Over a 30 min period, rats were assessed for the number of
times they engaged in rearing. Mechanical stimulation ameliorated the reduction in rearing that
was noted by chronic EtOH exposure alone (F(2,18) = 14.8194, p=0.0002; Fig. 4.3A). The chronic
EtOH rats engaged in rearing on average 22.57 times (±4.51). This was significantly fewer times
than rats treated with concurrent MStim (n=8 in all groups; p=0.0011 for EtOH and MStim;
p=0.0003 for EtOH and Sal). Mstim treated rats reared 46.29 times (±3.29) while saline treated
rats reared 49.86 times (±3.65). Open-field crosses were defined as the number of times the rats
crossed through the center 1/3 of the chamber in 30 min; it was also assessed. Mechanical
stimulation blunted the Chronic EtOH-induced reduction in the number of times rats engaged in
open-field crosses (F(2,18) = 18.8606, p<0.0001; Fig. 4.3B). The chronic EtOH rats crossed 14.14
times (± 1.94). This was significantly fewer than the 29.86 (±1.77) and 31.14 (±2.71) crosses
engaged in by the MStim and saline groups respectively (n=8 in all groups; p=0.0002 for EtOH
and MStim; p<0.0001 for EtOH and Sal; Figs. 4.3E-G). Tail stiffness and gait were subjectively
scored by two blinded assessors as further indicators of withdrawal status. Tail stiffness was
increased in the chronic EtOH when compared to the MStim or saline groups (F(2,18) = 36.1579,
p<0.0001; Fig. 4.3C). Tail stiffness in the chronic EtOH group was significantly different from
the other two and was scored 3.57/5 (±0.202) while the MStim and saline groups scored 1.86/5
(±0.261) and 1.14 (±0.143) respectively (n=8 in all groups; p<0.0001 for EtOH and MStim;
p<0.0001 for EtOH and Sal). Differences in gait patterns were noted between the three groups
(F(2,18) = 13.5789, p=0.0003; Fig. 4.3D). Gait scores for chronic EtOH animals were 3.43/5
(±0.369). The MStim animals scored 1.71/5 (±0.184) and the saline group scored 1.43 (±0.297).
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Chronic EtOH was significantly different from the other two (n=8 in all groups; p=0.0004 for
EtOH and MStim; p=0.0017 for EtOH and Sal). Thus, MStim, when applied concurrently with
chronic intermittent EtOH, is sufficient to ameliorate certain behavioral indices associated with
chronic EtOH withdrawal.

Discussion
We have previously reported that MStim acts on the nucleus accumbens to increase local DA
release and that this effect is mediated by activation of cholinergic and delta opioid receptors.
Further, projections from the NAc then cause a depression in VTA GABA neuron firing which
results in VTA DA neuron disinhibition and a subsequent increase in firing. The current study
was designed to investigate if these neuromodulatory changes are sufficient to alter chronic ethanol
effects on VTA GABA neurons and withdrawal behavior. In the present study, the effects of 80
Hz MStim treatment for 15 min BID given in-line with dependence-inducing chronic intermittent
EtOH injections were tested on various measures of EtOH withdrawal. While acute administration
of ethanol reduces VTA GABA neuron firing, chronic intermittent EtOH exposure desensitizes
VTA GABA neurons during reinstatement doses(Gallegos et al., 1999). These effects are thought
to occur through downregulation of D2 receptors in the VTA presumably due to EtOH-induced
alterations in local VTA DA release (Ludlow et al., 2009). Concurrent administration of MStim
with chronic intermittent EtOH blocks these effects and changes VTA GABA neuron response to
reinstatement from 117.5% of baseline to 32.7% of baseline. The blunting of the desensitization
was not sufficient to return the GABA neuron response back to a naïve state as there were
significant differences between the saline group and the EtOH + MStim groups. Mechanical
stimulation has been previously shown to increase DA levels in the NAc for 2 hrs post-MStim.
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These increased levels activate D1 and D2 expressing medium spiny neurons in the NAc that
project back to the VTA and target non-dopaminergic neurons (Xia et al., 2011). These projections
could be responsible for MStim-induced changes in VTA GABA neurons response to chronic
ethanol. These findings are particularly relevant as they represent a non-invasive method of
blocking chronic ethanol effects.
Dopamine levels were tested in the same chronic reinstatement paradigm. Animals naïve
demonstrated a characteristic increase in DA levels (Yim and Gonzales, 2000) following ethanol
injection. Animals treated with EtOH alone or MStim, whether in conjection with EtOH or not,
did not exhibit the same increase in DA levels following EtOH administration. This is suggestive
that MStim alone is sufficient to alter mechanistic changes normally elicited by the EtOH. Chronic
EtOH administration has been shown to increase expression levels of DORs while decreasing
expression of mu opioid receptors (Saland et al., 2005). As noted, we have previously shown that
MStim produces increased translocation of DORs to cellular membranes, this commonality
between EtOH and MStim could explain the desensitizing effects of MStim on acute EtOH
administration in EtOH naïve rodents. The MStim-induced alterations to chronic ethanol effects
on VTA GABA neurons and DA release in the NAc ultimately manifest in blunting of the noted
markers of dependence. The behavioral studies reported here buoy that finding as all measures of
withdrawal gathered for this study were substantively improved by the addition of MStim to the
chronic intermittent EtOH exposure paradigm employed to induce dependence. These data, when
taken as a whole suggest that MStim at 80 Hz could be a viable treatment option for the treatment
of alcohol-use disorder (AUD). This study is practically limited by the fact that MStim exposure
was given concurrently with EtOH exposure. It is less likely that individuals battling with AUD
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will receive MStim at the time of first exposure to alcohol. Future studies need to explore the
efficacy of MStim treatment in previously dependent animals.
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Figure Legends

Figure 4.1 – Effects of MStim on VTA GABA neuron firing rate after reinstatement ethanol
during withdrawal.
(A-C) Representative traces for GABA neuron response for (A) EtOH alone, (B) EtOH + MStim and (C)
saline + MStim. (D) Baseline firing rate differences between the three groups. Note that EtOH alone
maintained a higher baseline firing rate. (E) MStim blocks chronic EtOH-induced desensitization of GABA
neurons to EtOH reinstatement. (F) Time course data with 50 sec bins demonstrating disparate effects
among groups.. Asterisks *,**,*** indicate significance levels p<0.05, 0.01 and 0.001, respectively.

Figure 4.2 – Basal dopamine release in the NAc following EtOH injection (2.5g/kg IP).
(A) Summarized time course of EtOH enhancement of basal DA release in the NAc. Note that

naïve animals show distinct differences when compared to animal that received EtOH or MStim.
(B) Comparison of [DA] at 100 min post-injection. (C) Comparison of [DA] at 120 min post-injection.
Asterisks *,**,*** indicate significance levels p<0.05, 0.01 and 0.001, respectively.

Figure 4.3 – Blocking of EtOH-induced behavioral measures of withdrawal by MStim.
(A) Number of times the animal reared-up on hind legs in 30 min period. (B) Number of times the animal
crossed through the middle third of the chamber in a 30 min period. (C) Subjective rating of tail-stiffness.
(D) Subjective measure of the animal’s gait. Note that all measures improved with the concurrent
administration of MStim during chronic EtOH exposure. (E-G) Representative traces of the animals
movement patterns during testing.. Asterisks *,**,*** indicate significance levels p<0.05, 0.01 and 0.001,
respectively.
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Abstract
Exercise has increasingly been utilized as an adjunctive treatment for alcohol-use disorder (AUD).
This is in spite of sparse mechanistic understanding of neurologic effects influencing alcoholinduced substrate adaptations in the mesolimbic circuitry or elsewhere. These limitations blunt
practitioner’s efficacy in developing evidence-based guidelines for exercise recommendations for
AUD. Kappa opioid receptors (KORs) have been shown to increase sensitivity after chronic
alcohol exposure. In this study we demonstrate that voluntary exercise alone decreases expression
of KORs in the nucleus accumbens and the ventral tegmental area. These exercise-induced
changes competitively alter chronic ethanol-induced changes in KOR expression in these brain
regions. Curiously, we report that though voluntary exercises reduces ethanol seeking in
chronically exposed mice, it potentiates drinking in saline exposed mice.
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Introduction
It is estimated that over 28 million Americans are currently in need of treatment for alcohol abuse,
resulting in over $249 billion in direct costs [1]. Making matters worse, only 13% of those needing
intervention actually receive it. Thus, the economic, societal, familial, and personal costs
associated with AUD are staggering.

Kappa Opioid Receptors
KORs are expressed extensively in the Nucleus accumbens (NAc), both in the core and the shell
[2-4], where their activation inhibits DA release [2]. Data suggests that they are synthesized in
the cell bodies of DA neurons in the ventral tegmental area (VTA) where they are expressed and
also subsequently transported to terminals in the NAc where they are integrated into the
presynaptic membrane [5]. Activation of kappa receptors is associated with dysphoria [6].
Evidence suggests that there is an upregulation of the kappa opioid system in alcohol dependent
animals that may play a role in the increased seeking behavior seen with dependence [7]. This is
demonstrated by a decrease in dependent-state seeking behavior when the KOR antagonist norBNI is administered while having no effect on non-dependent animals [8]. Further chronic
intermittent ethanol exposure has been shown to increase the effect of KORs in the NAc These
data suggest a role for KORs in the synaptic adaptations that occur in dependence [6].

Exercise and the Mesolimbic Dopamine System
There is strong evidence that aerobic exercise is a beneficial adjunct to current pharmacological
and psychological treatment protocols. Exercise has been shown to produce a series of changes
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with relevance to the mesolimbic system. Aerobic exercise, similar to acute ethanol
consumption, has been shown to increase levels of tyrosine hydroxylase, the rate limiting
enzyme in DA synthesis, in the NAc [9, 10] (Macrae 1987). It has also been associated with
burst activation of DA neurons in the VTA [11](Wang and Tsien 2011). Further, 6-weeks of
voluntary wheel running in rats increased D2 auto receptor density in the NAc [10]; a
modification that has been associated with increased risk of addictive behavior [12-14].
However, exercise has been shown to increase D2R density in the dorsal striatum in a mouse
model of Parkinson’s disease [15].

Though the majority of evidence suggests an ameliorative

role for exercise [16, 17], there is intriguing evidence suggesting that excessive levels of exercise
can potentiate addiction [18, 19]. Currently, the causes of these outcome discrepancies has not
been shown. However, as there is very little consistency in methodology, type, intensity or
duration of treatment protocols, disparate recommendations might be to blame. Evidence for
opioid receptor changes with exercise is less concrete, appears to be highly region dependent
[20], and is lacking in the mesolimbic system. To our knowledge, no one has directly measured
changes in KORs in the ventral striatum in the context of exercise and ethanol. In this study we
hypothesize that voluntary wheel-running will down-regulate KORs in the NAc. We further
predict that exercise will block ethanol-induced sensitization of KORs and reduce alcohol
consumption in chronically exposed mice.

Material and Methods
Animals
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Male C57BL/6J and DBA/2J mice (Jackson Labs; aged 6-12 weeks) were given ad libitum access
to food and water, and were maintained on a reverse 12:12-h light/dark cycle (lights on at 15:00
h). Mice were randomly assigned to one of three cohorts, ethanol without exercise, ethanol with
exercise and saline with exercise. All mice were injected BID with ethanol (2.5g/kg; 16% w/v;
IP) or an equivalent volume of saline for 14 days. Exercise groups were given ad libitum access to
a running wheel. Intoxication was visually verified with loss of consciousness which decreased
visually with dependence. All protocols and animal care procedures were in accordance with the
National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by
the Brigham Young University Institutional Animal Care and Use Committee. All efforts were
made to minimize animal suffering and number of animals used in the present study.

Brain Slice Preparation
Isoflurane (Patterson Veterinary, Devens, MA) anesthetized mice were sacrificed by decapitation
and brains were rapidly removed and transferred into ice-cold, pre-oxygenated (95% O2/5% CO2)
artificial cerebral spinal fluid (aCSF) consisting of (in mM): NaCl (126), KCl (2.5), NaH2PO4
(1.2), CaCl2 (2.4), MgCl2 (1.2), NaHCO3 (25), glucose (11), L-ascorbic acid (0.4), pH adjusted to
7.4. Tissue was sectioned into 400 μm-thick coronal slices containing the striatum with a vibrating
tissue slicer (Leica VT1000S, Vashaw Scientific, Norcross, GA). Brain slices were placed in a
submersion recording chamber, and perfused at 1 ml/min at 32 °C with oxygenated aCSF.

Fast Scan Cyclic Voltammetry
Fast scan cyclic voltammetry (voltammetry) recordings of dopamine signals were performed and
analyzed using Demon Voltammetry and Analysis Software [Demon Voltammetry and Analysis;
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21]. The carbon fiber electrode (7 μm X ~150 μm) potential was linearly scanned as a triangular
waveform from -0.4 to 1.2 V and back to -0.4 V (Ag vs Ag/Cl) at a scan rate of 400 V/s. Cyclic
voltammograms were recorded at the carbon fiber electrode every 100 msec by means of a
potentiostat (Dagan Corporation, Minneapolis, MN). Dopamine release was evoked every 2 min
through a bipolar stimulating electrode 2. For input/output experiments examining baseline
dopamine signals across increasing current stimulations, single pulse baseline dopamine signals
were collected (4 ms, 350 μA) until signals were stable for across 3 collections. Baseline single
pulse responses were measured followed by concentration response for U50488 at 0.3 uM and 1
uM followed by a reversal dose of 1 uM nor-BNI; all drugs were bath applied. Each response was
gathered from single-pulse stimulations given 2 min apart before introduction of the next drug
concentration.

Preparation of Brain Slices for Imaging and Confocal Microscopy
Mice were anesthetized using isoflurane and underwent transcardial perfusion with 4%
paraformaldehyde (PFA). Once perfused, brains were carefully removed and placed in 4% PFA
for 24 hrs to facilitate continued fixation. After incubation in PFA, brains were placed in a solution
of 30% sucrose in 1X PBS until the density of the brain matched that of the solution and the brains
dropped to the bottom of the vial (~24-48 hrs). Brains were then flash frozen in dry ice and
mounted on a cold microtome stage. Targeting the VTA and NAc, brains were sliced at 30 µm on
the microtome and slices were placed in cryoprotectant (30% ethylene glycol, 30% sucrose,
0.00002% sodium azide, in 0.1 M PB) and kept at -20°C until staining. Slices were washed 3 times
in 1x PBS for 10 minutes on a rotator. They were then blocked with a blocking buffer comprised
of 4% normal goat serum, 0.1% Triton-X 100 and 1x PBS. Slices were then washed another 3
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times in 0.2% PBST on a rotator. Primary antibodies were applied and allowed to incubate for 20
hours. Following staining the slices were washed 3 times in 0.2% PBST and secondary antibodies
were applied. After a 2 hr incubation period they were washed another 3 times with 0.2% PBST
and once with 1x PBS. Antibodies included Mouse anti-tyrosine hydroxylase (Novus, 1:1328),
and Rabbit anti-KOR (LifeSpan, 1:200) as well as secondaries Alexa Fluor 405 Donkey AntiSheep from (1:900), Alexa Fluor 594 Goat anti-Rabbit (1:500). To mount slides, sections were
placed on microscope slides and dried ~5 min. Once dried, a drop of vectashield (Vector
Laboratories) was placed on the tissue, and a cover slip was placed on the slide. Slides set
overnight, and then they were kept at 4°C until imaging. An Olympus FluoView FV1000 confocal
microscope was used to image mounted slices. Brain slices were mounted on microscope slides
and imaged under oil immersion at 40X. To ensure consistent readings between samples, a
constant photomultiplier tube voltage and gain were set between all acquired images.

Statistical Analysis
For FSCV, evoked recordings were normalized to the established baseline within subjects and then
averaged across subjects in corresponding time intervals. Comparisons were made using a
Dunnett’s analysis. All statistical tests were performed in JMP13 (SAS, Cary, NC). Figures were
compiled using IGOR Pro Software (Wavemetrics, Lake Oswego, OR).
For brain slice imaging, images were loaded into FIJI software. Images were duplicated to
preserve the original settings while color thresholding and brightness contrast adjustments were
made to determine the location of cells and create ROIs. ROIs were then projected back onto the
unedited images where area and mean intensity were recorded for each channel. This process was
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performed by three independent raters blinded to the hypothesis. To determine relative density of
KORs, the ratio of mean fluorescence to area was determined.

Results
KOR effects on Dopamine Release in the Context of Exercise and Ethanol
Dopamine release was measured in each experimental group to measure changes in KOR activity
with application of U50488, a KOR agonist and reversal with nor-BNI, a KOR antagonist.
Significant differences were noted between the three groups at the 0.3 uM dose of U50488 (F(2,12)
= 20.4619, p=0.0001; Fig. 5.1). The ethanol no exercise group dropped to 81.4% (±4.1) of
baseline while the ethanol with exercise group only dropped to 94.5% (±2.0). Conversely, the
saline with exercise group increased evoked release to 108.3% (±4.2) (n=5 in all groups; p=0.0228
between Eth no Ex and Eth with Ex; p<0.0001 between Eth no Ex and Sal with Ex; p=0.0166
between Eth with Ex and Sal with Ex). When 1 uM U50488 was given the differences between
groups increased significantly (F(2,12) = 22.9751, p<0.0001). The ethanol no exercise group
dropped to 70.1% (±2.1) of baseline and the ethanol with exercise dropped to 84.7% (±3.8). The
saline with exercise remained generally unresponsive at 98.9% (±5.1) (p=0.0127 between Eth no
Ex and Eth with Ex; p<0.0001 between Eth no Ex and Sal with Ex; p=0.0150 between Eth with
Ex and Sal with Ex). Reversal with 1uM nor-BNI brought the ethanol no exercise, ethanol with
exercise and saline with exercise groups back to 100.2% (±5.5), 92.0% (±4.5) and 99.7% (±4.0)
respectively. There were no significant differences between these groups. This suggests that
exercise desensitizes KORs and blunts ethanol-induced sensitization of the receptors.
Immunohistochemical Analysis of KORs in the NAc and VTA
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Brain slices were acquired from each of the three groups in order to analyze expression patterns of
KORs in the NAc and VTA. Following analysis, significant differences were noted in average
MFI of KOR expressing cells in the NAc between the three groups (F(2,3162) = 353.7626, p<0.0001;
Fig. 5.2A-C and G). Average mean fluorescent intensity (MFI) of KOR expressing cells in the
ethanol no exercise group was 7.08 (±0.085) while the ethanol with exercise group was 3.52
(±0.125). The saline with exercise group MFI was 3.77 (±0.11). Notably the ethanol with exercise
group expressed an MFI similar to that of saline with exercise while both were significantly
different from the ethanol no exercise group (n=6 animals per group with 6 slices analyzed per
animal with multiple cells measured per slice; p<0.0001 between Eth no Ex and Eth with Ex;
p<0.0001 between Eth no Ex and Sal with Ex; p=0.4787 between Eth with Ex and Sal with Ex).
Expression patterns in the VTA followed the same trends as those in the NAc (F(2,1766) = 49.3301,
p<0.0001; Fig. 5.2D-F and H). The ethanol no exercise group was 5.46 (±0.15) and the MFI of
the ethanol with exercise was 3.84 (±0.16). The saline with exercise remained closely tied to the
other exercise group at 3.57 (±0.14) (n=same as in NAc; p<0.0001 between Eth no Ex and Eth
with Ex; p<0.0001 between Eth no Ex and Sal with Ex; p=0.4046 between Eth with Ex and Sal
with Ex). These findings indicate that exercise is sufficient to block ethanol-induced increased
expression of KORs in both the NAc and the VTA.

Effects of Exercise and Ethanol on Drink-in-the-Dark Behavior
To assess exercise and ethanol effects on drinking behavior, drinking was measured on 4
consecutive days. Significant differences were noted between the composite average of all groups
for all days (F(2,43) = 11.2596, p=0.0001; Fig. 5.3B). The ethanol no exercise group drank on
average 1.05g (±0.063) while the ethanol with exercise group drank 0.747g (±0.098).
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Interestingly, the saline with exercise group drank more than either with an average consumption
of 1.37g (±0.089) (Eth no Ex n=6, Eth and Ex n=3, Sal and Ex n=3; p=0.0323 between Eth no Ex
and Eth with Ex; p=0.0124 between Eth no Ex and Sal with Ex; p<0.0001 between Eth with Ex
and Sal with Ex). Ethanol consumption by day was significantly different only on days two and
three. On day two the ethanol with exercise and saline with exercise groups averaged 0.672g
(±0.16) and 1.51g (±0.13) respectively (p=0.009; Fig. 5.3A). On day three the ethanol with
exercise and saline with exercise groups averaged 0.575g (±0.14) and 1.52g (±0.14) respectively
(p=0.0035) while the ethanol no exercise group average 0.986g (±0.10) which was significantly
different from the saline with exercise group (p=-0.0382; Fig. 5.3B) Exercise significantly reduces
ethanol consumption in chronically exposed mice.

Discussion

In this study, KOR expression patterns were studied in the presence of ethanol and exercise to
better understand the role of exercise in the natural reward pathways. Chronic ethanol exposure
increases sensitivity of KORs while downregulating MORs and DORs in the NAc [22, 23]. We
have shown that activation of peripheral mechanoreceptors, potentially similar to what occurs in
consistent aerobic exercise, increases translocation of DORs to cellular membranes in the NAc
potentially in opposition to what occurs in after chronic ethanol exposure. Mechanosensory input
mediated through the dorsal column medial lemniscal pathway, provides collateral enervation,
outside the canonical somatosensory pathways that terminate in the somatosensory cortex. These
collaterals have been shown to alter neuron firing rate in the VTA [24] and influence
neurotransmitter release and DOR expression in the NAc. In this context we can properly examine
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the neurological effects of exercise in reference to their influence on the reward circuitry. Here we
find that voluntary exercise alone is sufficient to produce a reduction in KOR sensitivity to
U50488, a selective receptor agonist. It is important to note that mice in their natural habitat are
accustomed to consistent daily exercise and it is possible that reduction in sensitivity and
expression we report is actually the more normal state that a wild mouse would express and that
the abnormally sedentary lifestyle of a laboratory mouse produces alterations in KOR expression
due to lack of regular exercise. Regardless, it is evident that exercise directly influences the
expression of KORs in both the VTA and NAc. Additionally, exercise is capable of blunting some
of the increased expression of these receptors that normally accompanies chronic ethanol exposure.
We anticipated that because of these receptor changes that exercise would produce a reduction in
drinking behavior in ethanol exposed but exercised mice and certainly in saline exposed and
exercised mice. Indeed, exercise reduced drinking in chronically exposed mice. However, to our
surprise, saline treated mice exposed to exercise exhibited increased drinking behavior. It has been
reported that excessive levels of exercise carry the potential for dependence [18, 19] though no
mechanistic explanations has been proven. The dichotomous findings suggesting both that
exercise might be an effective adjunctive treatment for AUD while at the same time potentially
increasing risk are unexplored. Further mechanistic investigations focusing on MORs and DORs
in addition to KORs and the neurological circuits responsible for the mesolimbic effects of exercise
are required to fully explain exercise’s potential as an adjunctive treatment modality.
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Figure Legends
Figure 5.1: Exercise blocks ethanol-induced sensitivity of KORs in the NAc
Note that at concentrations of 0.03 uM U50488 and 1.0 uM U50488 there were significant
differences between all groups. Asterisks *** indicate significance levels p<0.001, while ##
indicates p<0.01.
Figure 5.2: Exercise alters ethanol-induced KOR expression in the NAc and VTA
(A-C) Representative images of KOR staining in the NAc demonstrating receptor expression
differences, KORs are red. (D-F) Same as A-C but in the VTA. (G,H) Group MFI data in the
NAc and VTA respectively, demonstrating that exercise decreases KOR expression in both brain
regions. Asterisks *** indicate significance levels p<0.001
Figure 5.3: Exercise decreases drinking in dependent but not naïve mice
(A) Time course data demonstrating per day consumption between experimental groups. (B)
Group showing composite drinking from all days. Note that all groups showed significant
differences. Asterisks * and*** indicate significance levels p<0.05 and 0.001
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CHAPTER 6: Discussion and Conclusions
Somatosensory Pathways Involved in Acupuncture-mediated Alterations to Mesolimbic
Structures
For millennia, mechanistic explanations of acupuncture’s purported effects have centered
on alterations to the balance of energy, or qi, meridians. These explanations have proven difficult
to reconcile with modern neuroscientific investigative techniques and advances which have
increasingly been used to explore the mechanistic underpinnings of an established body of
positive outcome data. Acupuncture in the treatment of drug-use disorders has been an area of
increasing western interest over the last decade. This interest has included hitherto unknown
explanations of its neurological effects at the cellular level. Mechanoacupuncture (MA) at the
HT7 acupoint, located medial to the flexor carpi ulnaris tendon at the wrist, has been shown to
reduce VTA GABA neuron firing rate and decrease ethanol consumption (Yang et al., 2010).
Further, the effects were shown to be mediated by delta opioid receptors (DORs) and initially
driven by the dorsal column medial lemniscal pathway through the nucleus cuneatus, thalamus,
and lateral habenula, not the spinothalamic tract, en route to altering firing rate in the VTA
(Chang et al., 2017). This preliminary work set a foundational understanding essential to
demystifying irrefutably positive outcome data that has been prejudicially discounted for
generations in the West. Further, they provided a potentially unifying insight into common
neurologically mechanistic explanation for the efficacy of manual therapeutics more generally;
these include chiropractic medicine, physical therapy, etc…). More broadly we can refer to these
disciplines as mechanoreceptor-based therapeutics. In light of these discoveries, this nonexhaustive body of work represents an attempt to further clarify, through mechanism and
outcome, the potential of mechanoreceptor-based therapies to play a role in the treatment of
drug-use disorders.
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Mechanoreceptor Activation as the Primary Driver of Mesolimbic Alterations without
Mechanoacupuncture
To determine the role of mechanoreceptors as the primary mediators of the mesolimbic
responses noted, a novel technique was needed to selectively activate peripheral
mechanoreceptors at a site distinct from HT7. We tested implantation of small vibrating motors
next to the C7-T1 veterbrae, at the laminae (Chapter 2) as a means of providing direct
stimulation to the DCML. These tests were successful in reducing VTA GABA neuron firing
purely through mechanical stimulation (MStim), without MA. This method also represents a
breakthrough in the studying of peripheral mechanoreceptor-based therapies. Previously, only
direct mechanistic data from the peripheral nervous system or indirect measures of central
nervous system effects had been reported.
Specificity of Effects relate to Mechanoreceptor Density and Type
Acupuncture stimulation at the wrist (HT7) or MStim at the cervical spine both represent
areas of high mechanoreceptor density. In order to determine the importance of
mechanoreceptors generally, we first tested the effects of MStim to an area relatively low in
receptors density, the mid-thigh. We found that an 80 HZ (120 sec) MStim to the belly of the
biceps femoris muscle was insufficient when compared to the effects noted by stimulation of the
cervical spine at the same intensity and duration (Fig 3.2A).
Because different subtypes of mechanoreceptors respond to different frequencies of stimulation.
Three frequencies were chosen to target specific mechanoreceptors and each was tested for 60
and 120 sec of stimulation. Of those chosen, 45 Hz enlists mostly Meissner’s corpuscles
(Macefield, 2005; Fleming and Luo, 2013), while 115 Hz is more selective for Pacinian
corpuscles (Zelena, 1978; Biswas et al., 2015). Both receptors are subcutaneously located. The
frequency of 80 Hz lies between the two and likely activates both receptors. Additionally, all
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three frequencies can activate Ruffini endings and Golgi tendon organs, two receptors that are
morphologically similar to one another and are important as joint mechanoreceptors (Vega et al.,
1996; Albuerne et al., 2000; Vega et al., 2009). The 50 and 80 Hz MStim produced a transient
depression of GABA neurons in the VTA, with 80 Hz (120 sec) producing the largest and
longest lasting effect. The 115 Hz stimulation failed to achieve VTA GABA neuron effects (Fig.
3.1). These data suggest that the effects of the MStim are likely mediated through Meissner’s
corpuscles, Merkel cells and Ruffini endings rather than Pacinian corpuscles. Further
simultaneous recordings from VTA DA neurons revealed that DA neuron firing increases,
following MStim, transiently for an average of 500 sec. This time course is inversely mirrored
by the described VTA GABA neuron depression. This is suggestive that the DA neuron firing is
due to disinhibition from GABAergic input locally in the VTA. More experiments are required
to fully determine the peripheral mechanoreceptors responsible for the described effects. One
potential method of exploration could include the use of the ChR2-Venus (ChR2V+) transgenic
rat line for optogenetic stimulation studies (National BioResource Project). The ChR2V+ line
uses the Thy 1.2 promotor to express the channelrhodopsin-2 (ChR2) transgene in myelinated
dorsal root ganglion neurons(Tomita et al., 2009; Honjoh et al., 2014). This line has been shown
to express ChR2 specifically in large diameter proprioceptive neurons, mainly Merkel Cells and
Meissner’s corpuscles, rather than small diameter, nociceptive neurons(Ji et al., 2012). This is
essential in the targeting of the DCML pathway and not the lateral spinothalamic tract. These
neurons will then be selectively stimulated with transcutaneous light. To date, optogenetic
stimulation has never been used to study mechanosensory modalities.
MStim Effects on NAc DA Levels are Locally Mediated by DORs and Acetylcholine Release
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Increased firing from VTA DA neurons, in the context of drug-abuse disorders, is most
relevant if it translates to increase DA release in the NAc. We performed microdialysis
experiments to measure changes in DA release following MStim. We anticipated that DA levels
would demonstrate a sharp increase immediately following the treatment and then return to
baseline. We were surprised to find that not only did MStim increase DA levels, the increase
peaked at 60 min post-stimulation and didn’t return to baseline 120 min post-stimulation. These
disparate effects in DA neuron firing and DA release were suggestive of two different etiologies.
We found that MStim-induced increases in NAc DA levels can be blocked by antagonizing
DORs in the NAc but not the VTA. Additionally, blockage of nicotinic and muscarinic
acetylcholine receptors in the NAc also blocks DA increases (Fig. 3.6). Delta opioid receptors
are located on local and projecting GABA neurons and cholinergic interneurons (CINs) in the
NAc. Cholinergic interneuron activity increases DA release by activation of nicotinic receptors
located on DA terminals. Activation of DORs in the NAc have been shown to increase DA and
we show that MStim increases translocation of DOR to cell membranes in the NAc. Two
theories could explain the DOR dependent increase of DA by MStim. First, increased release
could be through disinhibition of CINs and DA terminals, both of which receive GABAergic
input that is DOR dependent. Second, it is possible that direct activation of DORs on CINs
could cause increased firing even though DORs are known to be Gi coupled GPCRs. This could
occur through increased Ih or hyperpolarization currents which produce increased burst firing of
CINs. To better isolate the role of disinhibition of DA terminals via GABA neuron inactivation
versus increased Ih firing of CINs we could perform loose patch electrophysiological
experiments on CINs in the presence of DPDPE, a DOR agonist in the genetically modified
VGAT-CRE mouse strain. This strain marks VGAT expressing cells like GABA neurons with
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CRE which would allow us to virally inactivate them without effecting the CINs. This would
allow us to isolate the CINs and their specific responses to DOR activation and determine if burst
firing occurs. Further, exploration with fast-scan cyclic voltammetry would allow us to measure
evoked DA release response to DOR activation without the interference of DOR expressing
GABA neurons. These experiments would allow us to more fully understand the interplay
between DORs on CINs and those on GABA neurons in the MStim-induced DA increases.
A Working Model of MStim Effects in the Mesolimbic Circuitry
We developed a working model of a proposed mechanism by which MStim effects the
VTA and NAc (Fig. 6.1). We propose that signals from peripheral mechanoreceptors are
transduced through the DCML to the VPL thalamus. From there signals pass to the lateral
habenula which sends glutamatergic projections to the NAc. Glutamate receptors on D2
expressing medium spiny neurons (D2 MSNs) increase their activity. These D2 MSNs release

Figure 6.1 – A working model explaining MStim effects on the mesolimbic circuitry.
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met-Enkephalin, an endogenous ligand to the DOR. They also project back to the VTA via the
indirect pathway and ultimately inhibit firing of local VTA GABA neurons, which results in a
transient inhibition of VTA DA neuron firing. The importance of this NAc to VTA projection
was verified by local lidocaine injection into the NAc; it blocked MStim-induced depression of
VTA GABA neuron firing. Local NAc collaterals from D2 MSNs activate DORs on local
GABA interneurons which cause CIN and DA terminal disinhibition; both of which result in
increased DA release. Several important factors remain unknown in this process. The effects of
mechanoacupuncture have been shown to be glutamate dependent in the NAc (Kim et al., 2018).
The precise origin of these fibers is not known. This could be determined experimentally using
dual single unit recording. One potential target for these studies is the rhomboid nucleus of the
thalamus. It contains efferent projections that enervate the NAc and the other limbic structure
(Vertes et al., 2006). These studies would provide direct evidence that neurons in the thalamus
fire in tandem with neurons in the NAc or in the VTA.
MStim Blockage of Markers of Chronic Ethanol Dependence
Normally, a reinstatement dose of ethanol after 24 hours of withdrawal in the dependent animal
will not cause a depression in VTA GABA neuron firing rate. This demonstrates the
desensitization that occurs because a naïve animal will show a massive decrease in the presence
of ethanol. Animals received MStim, via whole-body vibration at 80 HZ for 15 min BID,
reacted to reinstatement ethanol in a manner that more closer resembles a saline treated animal
(Chapter 5). Further, behavioral measures of dependence are largely mitigated with the addition
of MStim to the process of dependence. Several possible explanations exist for this observed
phenomenon. First, chronic ethanol has been shown to decrease DOR affinity in the NAc. We
have shown that MStim significantly increases translocation of DORs to cellular membranes in
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the NAc 2 hours post-MStim. These competing effects could be responsible for the protective
influence of MStim over the normal adaptations resultant from chronic ethanol exposure. To
further understand how MStim blocks measures of dependence after chronic ethanol exposure
more study will be required. Evidence suggests that kappa opioid receptors (KORs) and mu
opioid receptors (MORs) are important in chronic ethanol-induced mesolimbic adaptations with
KORs increasing expression and MOR decreasing expression after chronic ethanol exposure.
Both KORs and MORs need to be studied to determine if MStim alters their expression.
Immunohistochemistry analysis of their expression patterns after MStim and colocalization with
tyrosine hydroxylase and D2 receptors would help us isolate expression patterns on DA
terminals, GABA neurons and CINs in the NAc.
Exercise and Ethanol Dependence
In chapter 5 we demonstrate that voluntary wheel running is sufficient to alter expression
of KORs in the NAc and the VTA and their influence on evoked DA release in the NAc. These
changes hold after chronic ethanol exposure. Further, ethanol drinking behavior was
substantially reduced with exercise. Paradoxically, exercise without chronic ethanol increased
drinking behavior even while decreasing expression of KORs, opposite to the effect elicited by
chronic ethanol. It is noted that previous studies have reported conflicting results related to
exercise as a treatment for drug-use disorders. Some reporting positively and some even
showing potentiation of the condition (Ehringer et al., 2009; Berczik et al., 2012; Wang et al.,
2014; Leasure et al., 2015). The direct connection between exercise and MStim is unknown.
Interestingly, no one has ever published a direct mechanistic explanation of how exercise exerts
its effects on the mesolimbic system. It remains unstudied whether these effects are mediated by
cardiovascular means or in a more neurologically direct pathway similar to MStim. However,
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logically, exercise activates mechanoreceptors. To date, no has reported real-time changes in
neuron firing in connection with exercise. Such studies could be performed with an anesthetized
rat whose head is sterotaxically stationary being placed on a treadmill. Natural reflexive
responses would allow the rat to engage in treadmill running while electrophysiological
measurements of neurons are taken. Additionally, these results could be compared to changes
induced by passive motion of limbs versus pharmacological cardiovascular stress testing.
Obviously, DOR and MOR changes with exercise would provide needed mechanistic
understanding as well. Finally, intensity of exercise could be a major player in the explanation
of disparate outcomes related to exercise as a treatment modality (Ni et al., 2012).
Conclusions and Future Directions
Mechanical stimulation holds great promise as an adjunctive treatment approach during
acute medical detox, residential and outpatient addiction recovery programs. The nonpharmacological ability to alter GABA firing rate in the VTA and increase local DA release in
the NAc is an astounding finding that warrants more exploration. Because of the high level of
safety associated with this type of therapy, it hold the potential to provide a step forward in light
of the low levels of efficacy of current treatment approaches. It creates the possibility to
collaborations with alternative health-care providers including doctors of chiropractic,
acupuncture and physical therapy. Future studies should continue to explore the mechanistic
science behind MStim effects including, thalamic to NAc connections and the involvement of
MORs and KORs. Future testing should also include testing in animals that have become
dependent before MStim has been introduced to test its efficacy as a recovery modality.
Obviously, translational studies in humans are required to test these effects in the human
population. Optimal durations and frequency of treatments must to be explored to maximize
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changes to the neuronal substrates discussed and to maximally alter behavioral outcomes. It is
hoped that this work will lay a foundation to for a new treatment to improve outcomes for those
struggling to overcome drug-use disorders.
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